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Mitochondrial superoxide (O2
,) underlies much
oxidative damage and redox signaling. Fluorescent
probes can detect O2
,, but are of limited applica-
bility in vivo, while in cells their usefulness is con-
strained by side reactions and DNA intercalation. To
overcome these limitations, we developed a dual-
purpose mitochondrial O2
, probe, MitoNeoD, which
can assess O2
, changes in vivo by mass spectrom-
etry and in vitro by fluorescence. MitoNeoD com-
prises a O2
,-sensitive reduced phenanthridinium
moiety modified to prevent DNA intercalation, as
well as a carbon-deuterium bond to enhance its
selectivity for O2
, over non-specific oxidation, and
a triphenylphosphonium lipophilic cation moiety
leading to the rapid accumulation within mitochon-
dria. We demonstrated that MitoNeoDwas a versatile
and robust probe to assess changes in mitochondrial
O2
, from isolated mitochondria to animal models,
thus offering away to examine themany roles ofmito-
chondrial O2
, production in health and disease.
INTRODUCTION
The production of O2
,within themitochondrial matrix varies un-
der different conditions (Murphy, 2009; Winterbourn, 2008).
Matrix O2
, can initiate oxidative damage and can also dismu-
tate to hydrogen peroxide (H2O2), which initiates redox signaling
(Fourquet et al., 2008; Holmstrom and Finkel, 2014). Conse-
quently, there is considerable interest in assessing the causes
and effects of mitochondrial O2
, production in vitro and in vivo;
however, progress is hampered by the technical difficulties of
assessing O2
, (Halliwell and Whiteman, 2004; Kalyanaraman
et al., 2014; Murphy et al., 2011).
Fluorescent probes based on hydroethidine (HE, dihydroe-
thidium) such as HE, the mitochondria-targeted derivativeCell Chemical Biology 24, 1285–1298, Octob
This is an open access article undMitoSOX Red (Robinson et al., 2006; Zielonka and Kalyanara-
man, 2010), and themembrane-impermeant analogue hydropro-
pidine (Michalski et al., 2013) are used to assess O2
,. Initially it
was thought that HE was oxidized by O2
, to the fluorescent
product ethidium (E+), but Kalyanaraman and colleagues then
showed that HE reacts with O2
, to form 2-hydroxyethidium
(2-OH-E+) (Zhao et al., 2003), while the production of E+ from
HE can arise from many oxidants (Zielonka and Kalyanaraman,
2010). HE is first oxidized by O2
, to a radical cation, which
then reacts with another O2
, to form a hydroperoxide adduct
that rearranges to 2-OH-E+ (Figure S1) (Michalski et al., 2013,
2014). However, the radical cation can also be formed by reac-
tion with other oxidants, followed by further oxidation (or dispro-
portionation) to E+ (Figure S1). Therefore, while the formation of
2-OH-E+ from HE is a robust indication of O2
, generation, pro-
duction of E+ from HE is not. Unfortunately, as the fluorescence
of E+ and 2-OH-E+ overlap, and as E+ is often formed to a greater
extent than 2-OH-E+, the assessment of O2
, in cells through
fluorescence by microscopy or flow cytometry is susceptible
to artifact (Zielonka and Kalyanaraman, 2010). Therefore, to
assess O2
, production reliably the E+ and 2-OH-E+ products
of HE and its derivatives have to be separated by high-pressure
liquid chromatography (HPLC) followed by detection by fluo-
rescence or mass spectrometry (Kalyanaraman et al., 2014;
Maghzal and Stocker, 2007; Michalski et al., 2014; Zielonka
and Kalyanaraman, 2010).
Another factor affecting the fluorescence of E+ and 2-OH-E+ is
that both intercalate into DNA and double-stranded RNA (Horo-
bin et al., 2013), thereby increasing the fluorescence quantum
yield by 10- to 40-fold (Zhao et al., 2005; Zielonka et al., 2008)
(Michalski et al., 2013) (Figure S1). The intercalation of the phe-
nanthridinium oxidation products, E+ and 2-OH-E+, into DNA in-
creases fluorescence in regions of the cell where DNA is abun-
dant not just where O2
, generation is elevated. This relocation
from the cytosol to the nucleus (Horobin et al., 2013; Meany
et al., 2007) and intercalation also makes such phenanthridinium
salts toxic to DNA (Hashiguchi and Zhang-Akiyama, 2009). For
these reasons, it would be good to separate the O2
,-sensing
capabilities of HE analogues from their problematic interaction
with DNA (Cairns et al., 2014).er 19, 2017 ª 2017 The Author(s). Published by Elsevier Ltd. 1285
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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To overcome these limitations, we modified HE to develop a
mitochondria-targeted O2
, probe designed to produce phenan-
thridinum oxidation products that would not intercalate into DNA,
and which could be used in vivo. Prevention of DNA intercalation
was achieved by attaching bulky neopentyl groups to the 3- and
8-amino substituents on the phenanthridinium core (Figure 1A).
Targeting to mitochondria was achieved by conjugation to the
lipophilic triphenylphosphonium (TPP) cation, which drives the
accumulation of drugs and probes into mitochondria in response
to the membrane potential in cells and in vivo (Smith et al., 2011,
2012) (Figure 1B). To enhance probe stability in the presence of
air and light, and to increase O2
, selectivity, we also incorpo-
rated a deuterium at C-6 (Kundu et al., 2010). The rationale is
that the oxidation of HE to either 2-OH-E+ or E+ requires cleavage
of the C-H bond at C-6 on the hydrophenanthridine core of HE
(Figure S1). Breaking this bond is the rate-limiting step of the
spontaneous oxidation of HE to E+, probably occurring by
hydrogen atom transfer, leading to a large kinetic isotope effect
(KIE) of 4.7 (Kundu et al., 2010). In contrast, this C-H/D bond
contributes less to the rate-limiting step for the reaction of HE
with O2
,, giving a KIE of 2.5 (Kundu et al., 2010). Therefore
deuterium incorporation should decrease background oxidation
more than the O2
,-specific reaction, thereby increasing selec-
tivity for O2
, (Kundu et al., 2010). The precursor to our O2
,
probe, MitoNeo (Figure 1A), can be chemically reduced to the
O2
,-sensitive probe MitoNeoD prior to use. While most O2
,
generated within mitochondria will most likely be converted
to H2O2 by the action of Mn superoxide dismutase (SOD), the
remaining small pool of O2
, should react selectively with
MitoNeoD to generate MitoNeoOH (Figure 1A), with non-specific
oxidation generating MitoNeo (Figure 1A). The untargeted
analogue, Neo, was also made and can be similarly reduced to
NeoD (Figure S2A), which should react with O2
, to generate
NeoOH, reporting onO2
,-production in the cytosol (Figure S2B).
To extendMitoNeoD to assess the production of O2
, bymito-
chondria in vivo we used the exomarker approach (Logan et al.,
2014). For this, the probe is administered in vivo and there reacts
with the species of interest to form an exomarker that is ex-
tracted and assayed ex vivo by mass spectrometry (Cocheme´
et al., 2011, 2012; Logan et al., 2014; Pun et al., 2014) (Figure 1B).
This approach enables changes in the levels of reactive species
within the mitochondria in vivo to be determined. We have done
this previously for MitoB, in which a TPP moiety is used to target
a H2O2- and peroxynitrite-reactive boronic acid moiety to mito-
chondria, which there reacts to form a diagnostic exomarker
MitoP (Cocheme´ et al., 2011, 2012). The MitoP/MitoB ratio canFigure 1. Selective Detection of O2
,– Using MitoNeoD
(A) Reaction of MitoNeoD/H or NeoD/H with O2
, generates MitoNeoOH or Neo
groups (blue) prevent intercalation into DNA.
(B) MitoNeoD uptake by mitochondria and reaction with O2
,. The membrane
followed by its O2
,-dependent reaction to form MitoNeoOH, while the non-spe
detected by confocal microscopy, or by extraction followed by LC-MS/MS to all
(C) Synthesis of MitoNeo, MitoNeoH/D, andMitoNeoOH. 3,8-Diamino-6-phenylph
presence of sodium triacetoxyborohydride and trifluoroacetic acid (TFA) to give
nitrogen atom was achieved using 6-bromohexyl triflate 3 to afford N-(bromohex
toluene under reflux to furnish MitoNeo. d15-MitoNeo was prepared from N-(brom
Reduction of MitoNeo in a two-phasewater-dichloromethanemixture under argon
MitoNeoH/D with Fremy’s salt (potassium nitrosodisulfonate) in acetonitrile (ACN
See also Figures S1 and S2.then be assessed ex vivo to infer changes in the concentration
of these reactive species within the mitochondria of a living
organism. To facilitate quantification, these species were
measured relative to deuterated internal standards by liquid
chromatography-tandem mass spectrometry (LC-MS/MS) after
extraction from the tissue. A further advantage of the TPP cation
is that its fixed positive charge greatly enhances the sensitivity
for compound detection by mass spectrometry, enabling the
measurement of pmol/g levels in tissue, while the ratiometric
measurement of MitoP andMitoB corrects for changes in uptake
in vivo (Cocheme´ et al., 2011, 2012). By extension, we can inject
MitoNeoD into a living organism, where it should be taken up into
mitochondria, and converted by O2
, to MitoNeoOH. Subse-
quent extraction of the tissue ex vivo and quantification of the
amounts of MitoNeo and MitoNeoOH by LC-MS/MS relative to
deuterated internal standards should enable changes in forma-
tion of mitochondrial O2
, in vivo to be assessed. Here we report
on the development of MitoNeoD and show that it enables the
detection of mitochondrial O2
, by fluorescence and by mass
spectrometry in cells and in vivo (Figure 1B).
RESULTS
Synthesis and Properties of MitoNeoD
MitoNeoD (Figure 1A) incorporates bulky neopentyl groups
to prevent DNA intercalation, while having similar electron-
donating properties to the 3- and 8-amino substituents of HE,
which ensures high reactivity with O2
, and prevents ring open-
ing of the oxidation products to form pseudobases (Bunting and
Meathrel, 1974). The neopentylamino groups are alsomore acid-
stable than tertiary butyl derivatives and do not sterically impede
the reaction with O2
,. These electronic and steric properties
played a significant role in the chemical synthesis of MitoNeoD
(Figure 1C). The neopentyl groups were introduced by reductive
amination of 3,8-diamino-6-phenylphenanthridine 1 with pivalal-
dehyde giving a relatively electron-rich phenanthridine 2. This
allowed selective N-alkylation of the phenanthridine in the
presence of the arylamino groups to furnish the bromo-derivative
4. Displacement of the bromide by triphenylphosphine or d15-tri-
phenylphosphine afforded MitoNeo and d15-MitoNeo, respec-
tively, the latter of which is required for LC-MS/MS quantification
(Cocheme´ et al., 2011).
MitoNeo is reduced to MitoNeoH/D by sodium borohydride/
borodeuteride (Figure 1C), and it is this hydrophenanthridine/
deuterophenanthridine form that will be used to assess O2
, for-
mation. MitoNeoH/D should react selectively with O2
, to formOH, while non-specific oxidation forms MitoNeo or Neo. The bulky neopentyl
potential-dependent uptake of MitoNeoD by mitochondria in cells is shown,
cific oxidation product MitoNeo is also formed. MitoNeoOH formation can be
ow detection of mitochondrial O2
, in vivo.
enanthridine 1 underwent double reductive amination with pivalaldehyde in the
the bis(neopentyl) derivative 2. Selective N-alkylation of the phenanthridine
yl)phenanthridinium salt 4, which was then reacted with triphenylphosphine in
ohexyl)phenanthridinium salt 4 in the same way using d15-triphenylphosphine.
by NaBH4/NaBD4 gaveMitoNeoH/D.MitoNeoOHwas prepared by reaction of
) and pH 7.4 phosphate buffer.
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Figure 2. Optical Properties of MitoNeo and Its Derivatives
(A) UV-visible spectra of MitoNeo, MitoNeoOH, and MitoNeoH (25 mM of each) in ethanol.
(B–D) Fluorescence spectra of MitoNeo and/or MitoNeoOH (25 mMof each in KCl buffer). (B) Fluorescence spectra of MitoNeo and/or MitoNeoOH as a function of
excitation and emission wavelength, shown in 3D (upper) and 2D (lower) views. (C) Emission fluorescence spectra of MitoNeo and MitoNeoOH. Excitation
wavelengths: 566 nm (MitoNeo), 544 nm (MitoNeoOH). (D) Excitation fluorescence spectra of MitoNeo and MitoNeoOH. Emission wavelengths: 636 nm
(MitoNeo), 605 nm (MitoNeoOH).
(E) Concentration dependence of fluorescence of MitoNeoOH and MitoNeo at the excitation (544 nm) and emission (605 nm) maxima of MitoNeoOH.
See also Figure S3 and Table S1.MitoNeoOH, and non-specifically with other oxidants to form
MitoNeo (Figure 1A). MitoNeoOH is produced selectively
because the transformation requires two distinct features of
O2
,: its reactivity as a nucleophilic radical and the presence
of a hydroxide leaving group in the resulting adduct. The syn-
thetic compound, Fremy’s salt (potassium nitrosodisulfonate),
which shares these two characteristics and mimics the chemis-
try of the O2
, reaction (Zielonka et al., 2008), was used to pre-
pare a definitive sample of MitoNeoOH from MitoNeoH (Fig-
ure 1C). We also report the synthesis of NeoH/D and the
corresponding oxidation products NeoOH and Neo (Figure S2A),
which will not be targeted to mitochondria and should instead
report on O2
, production in the cytosol (Figure S2B).
The UV-visible absorption spectra of the MitoNeo and Neo
compounds are shown in Figures 2A, S3A, and S3B. There is
minimal interference of MitoNeoH absorption with MitoNeo/
MitoNeoOH above 400 nm, and significant MitoNeoH absorp-1288 Cell Chemical Biology 24, 1285–1298, October 19, 2017tion at 385 nm, where there is minimal absorption by the
oxidized forms. The local absorption maxima and extinction co-
efficients are given in Table S1.
The fluorescence of MitoNeo and MitoNeoOH is shown in Fig-
ure 2B. MitoNeoH/D are not fluorescent at these wavelengths.
The excitation and emission maxima for MitoNeo are in the range
of 540–580 and 600–650 nm, respectively, and for MitoNeoOH
are in the range of 520–560 and 580–620 nm, respectively. To
refine these assignments, we assessed the emission (Figure 2C)
and excitation (Figure 2D) spectra for MitoNeo and MitoNeoOH,
from which we could infer excitation/emission maxima of 566/
636 nm for MitoNeo and 544/605 nm for MitoNeoOH (Table
S1). The emission (Figures S3C and S3D; Table S1) and excitation
(Figure S3E; Table S1) spectra for Neo and NeoOH are similar.
The negligible MitoNeoD fluorescence may facilitate monitoring
of the oxidation of MitoNeoD to MitoNeoOH, and excitation
at shorter wavelength should minimize interference from the
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Figure 3. Fluorescence and NMR Analysis
of Reaction of MitoNeoH/D with O2
,–
(A) Excitation fluorescence spectra over time.
MitoNeoH (10 mM) was incubated at 37C in KCl
buffer with 1 mM hypoxanthine (HX) and 5 mU/mL
xanthine oxidase (XO) and the excitation spectrum
was assessed at various times using an emission
wavelength of 605 nm.
(B and C). Time courses of reaction of MitoNeoH
(B) or MitoNeoD (C) with O2
,.
MitoNeoH or MitoNeoD (10 mM) was incubated
with 1 mMHX and 5mU/mL XO, in the presence of
10 mg/mL SOD or 50 U/mL catalase in KCl buffer at
37C. Excitation and emission wavelengths were
544 and 605 nm, respectively.
(D) 1H NMR analysis of reaction product of NeoD
with O2
,. The upper 1H NMR spectrum is of
NeoOH in CDCl3, synthesized from NeoH using
Fremy’s salt. For the lower spectrum, NeoD
(100 mM) was exposed to O2
, by incubation with
XO (0.5 U/mL) and HX (1 mM) for 3 hr in a 1:0.5:3.5
mixture of EtOH:PBS:H2O and then extracted into
CHCl3, purified by HPLC and the
1H NMR spec-
trum obtained. The expansion is of the aromatic
region of the spectrum where only the numbered
protons of the phenanthridinium moiety and
those on the 6-phenyl group appear (red on the
MitoNeoOH structure).
See also Figure S4.non-specific oxidation product, MitoNeo. To determine if this is
the case we assessed the relative fluorescence of MitoNeo and
MitoNeoOH at the excitation/emission maxima for MitoNeoOH
(544/605 nm) (Figure 2E), which showed that the fluorescence in-
crease with concentration is four times greater for MitoNeoOH
than forMitoNeo, with similar selectivity for NeoOH over Neo (Fig-
ure S3F). Therefore fluorescence changes are partially selective
for the O2
,-sensitive reaction of MitoNeoD.
Analysis of MitoNeoH/D Reactivity with O2
,–
Wenext assessed the reaction ofMitoNeoHwith O2
,, generated
by hypoxanthine/xanthine oxidase. The fluorescence excitation
spectrum of MitoNeoOH increased over time upon exposure to
O2
, (Figure 3A). The excitation maximum was similar to that
for MitoNeoOH (544 nm) rather than that for MitoNeo (566 nm),
consistent with the reaction primarily generating MitoNeoOH.
We then assessed the changes in fluorescence over time at the
optimal wavelengths for MitoNeoOH (544/605 nm; Figure 3B).
This showed little spontaneous oxidation of MitoNeoH, while
there was a dramatic increase on exposure to O2
,. This increase
was blocked by degradingO2
,with SOD, but not by intercepting
H2O2 with catalase (Figure 3B). To see how incorporation of a
deuterium atom at C-6 affected oxidation, we exposedMitoNeoD
to O2
, (Figure 3C). MitoNeoH and MitoNeoD were qualitatively
the same; however, the fluorescence of the oxidation products
of MitoNeoD increased 2.9 times more slowly than MitoNeoH
(Figure 3C). NeoH exposed to O2
, also showed oxidation
consistent with the formation of NeoOH (Figures S4A–S4C),
with NeoD being oxidized approximately half as fast as NeoH
(Figure S4D). These data are consistent with the O2
,-specific
oxidation of MitoNeoD to MitoNeoOH.
To determine whether the NeoOH/MitoNeoOH synthesized
using Fremy’s salt are the same as the products of the reactionofMitoNeoD or NeoDwith O2
, and to confirm the hydroxyl loca-
tion in MitoNeoOH/NeoOH, we analyzed the product of the reac-
tion of NeoD with O2
, by nuclear magnetic resonance (NMR)
(Figures 3D and S4E–S4I). The upper 1H NMR spectrum in Fig-
ure 3D is of authentic NeoOH, synthesized from NeoH using
Fremy’s salt (Figure S2A). When NeoD was exposed to O2
,
the 1H NMR spectrum (Figure 3D, lower spectrum) was essen-
tially identical to that of authentic NeoOH. Together, these data
are consistent with the O2
,-dependent selective oxidation of
MitoNeoD to MitoNeoOH.
Reverse-PhaseHPLCAnalysis of Reactions ofMitoNeoD
with O2
,– and Other Reactive Oxygen Species
MitoNeo, MitoNeoH/D and MitoNeoOH can be separated by
reverse-phase HPLC (RP-HPLC) (Figure 4A), so we used this to
assess their relative stability and reactivity with O2
,. As antici-
pated, in the absence of O2
, MitoNeoD was more resistant to
spontaneous oxidation to MitoNeo than was MitoNeoH (Fig-
ure 4B), with 3-fold more oxidation of MitoNeoH compared
with MitoNeoD, consistent with their relative KIEs. Incubation
with O2
, led to the formation of MitoNeoOH and MitoNeo over
time (Figure 4C). Although MitoNeo was formed it contributed lit-
tle to the fluorescence optimized for MitoNeoOH. Exposure of
MitoNeoD to O2
, led to more formation of MitoNeoOH relative
to MitoNeo than for incubation with MitoNeoH (Figure 4C), with
the ratio of the peak areas of MitoNeoOH to MitoNeo being
0.8 for MitoNeoH after an hour, while for MitoNeoD this was
2. In contrast, under background conditions (Figure 4B), the
same ratios were 0.3 and 0.7, respectively. Degradation of
O2
, by SOD prevented the accumulation of MitoNeoOH, but
there was still some MitoNeo formation (Figure 4D), and the
MitoNeoOH/MitoNeo ratios were about the same as occurred
during background oxidation. Exposure of MitoNeoD to otherCell Chemical Biology 24, 1285–1298, October 19, 2017 1289
A B
C D
Figure 4. RP-HPLC Analysis of MitoNeoD
Reaction with O2
,–
(A) RP-HPLC chromatogram of a mixture of
MitoNeoH, MitoNeo, and MitoNeoOH (10 nmol of
each), assessed by absorbance at 220 nm and by
fluorescence at the excitation (550 nm) and emis-
sion (590 nm) peaks for MitoNeoOH, under RP-
HPLC conditions.
(B) Stability ofMitoNeoH andMitoNeoD. RP-HPLC
of MitoNeoH or MitoNeoD (100 mM) incubated in
KCl buffer at 37C. At the indicated times, 10 nmol
aliquots were removed and analyzed by RP-HPLC.
(C) Reaction of MitoNeoH and MitoNeoD with
O2
,. RP-HPLC of MitoNeoH or MitoNeoD
(100 mM) incubated in KCl buffer at 37Cwith 1mM
HX and 5 mU/mL XO. At the indicated times,
10 nmol aliquots were removed and analyzed by
RP-HPLC.
(D) Effect of SOD on the reaction of MitoNeoH and
MitoNeoD with O2
,. RP-HPLC of MitoNeoH or
MitoNeoD (100 mM) incubated in KCl buffer (pH
7.2) at 37C with gentle shaking 1 mM HX and
5 mU/mL XO supplemented with 10 mg/mL SOD.
At the indicated times, 10 nmol aliquots were
removed and analyzed by RP-HPLC.
See also Figure S5.biologically relevant reactive oxygen species (ROS) showed
negligible formation of MitoNeoOH (Figure S5A). Thus, MitoNeoD
is more stable than MitoNeoH, the formation of MitoNeoOH only
occurs in the presence of O2
,, and MitoNeoD is more selective
for O2
, than MitoNeoH.
Reaction of MitoNeoH/D with O2
,– Measured by Pulse
Radiolysis
To investigate the mechanism of the reaction of MitoNeoH/D
with O2
,, the rates of the first one-electron oxidation
step (Figure S1) were analyzed by pulse radiolysis. The spec-
trum of the radical cation formed by the one-electron oxidation
of MitoNeoH in water-ethanol at pH 6 (Figure S5B), where the
a-hydroxyethylperoxyl radical is the oxidizing species, is1290 Cell Chemical Biology 24, 1285–1298, October 19, 2017similar to the aniline radical cation,
which absorbs in the 400–450 nm region
(Qin et al., 1985); the shift to longer
wavelengths for the radical cation of
MitoNeoH is expected for N-substituted
aniline radicals (Christensen, 1972). The
one-electron oxidation of MitoNeoH in
water-ethanol solution at pH 11, where
O2
, is the oxidizing species, generates
the deprotonated anilino radical (pKa
7.1), which absorbs in the same region
as the aniline radical cation, but with
much lower intensity (Figure S5B). The
formation of these products at 475 nm
was used to determine the rates
of reaction with O2
, (Figure S5B,
inset): MitoNeoH = 1.25 ± 0.01 3 107
M1 s1; MitoNeoD = 1.42 ± 0.04 3
107 M1 s1 (Figure S5C). The reactionof NeoH and NeoD with O2
, gave rate constants of: 1.08 ±
0.07 3 107 and 1.09 ± 0.13 3 107 M1 s1, respectively (Fig-
ure S5D). Hence, deuterium incorporation did not lead to a pri-
mary KIE. A previous assessment of the reaction of HE with
O2
, by pulse radiolysis in 1:1 water:ethanol at pH 8 gave k =
2 3 106 M1 s1 (Zielonka et al., 2006), consistent with our re-
sults. However, these authors now favor far lower rates for this
reaction (6 3 103 M1 s1 for HE and 1.4 3 104 M1 s1 for
MitoSOX Red, based on a competition assay with SOD [Mi-
chalski et al., 2013]). These authors discounted the earlier
pulse radiolysis measurements because the protonated form
of O2
,, the perhydroxyl radical (HO2
,), may have dominated
the reaction. However, this is unlikely because the pKa of
HO2
, in water is 4.8 (Bielski et al., 1985). Our view is that
both measurements are correct: the rate constants deter-
mined by the competition assay are for the overall reaction,
while those determined by pulse radiolysis are for the first
step only, which is not rate determining. This is consistent
with our observations that there is no KIE for the first one-elec-
tron oxidation, but that the overall reaction with O2
, is slower
for MitoNeoD/NeoD than for MitoNeoH/NeoH (Figures 3B, 3C,
S4C, and S4D). An overall rate of104 M1 s1 for the reaction
of MitoNeoD with O2
, is far less than the rate for the reaction
of O2
, with MnSOD (2 3 109 M1 s1), hence MitoNeoD will
report on O2
, levels without distortion of its concentration.
The lack of a KIE by pulse radiolysis rules out hydrogen atom
abstraction from the C-6 of MitoNeoH by O2
, as the first step in
the reaction. However, these data are consistent with one-elec-
tron oxidation by O2
, forming a radical cation (Zielonka et al.,
2006), as is shown in Figure S5E. There is then a larger KIE for
the deuterium atom transfer from the radical intermediate to
form MitoNeo, than for the alternative reaction sequence with
O2
, to form MitoNeoOH (Figure S5E), in which the C-6 deute-
rium atom is lost by deuteron transfer. Thus, MitoNeoD exhibits
greater selectivity than MitoNeoH for the reaction with O2
, to
form MitoNeoOH over the competing oxidation to MitoNeo.
MitoNeo and Neo Do Not Intercalate into DNA
To assess whether the neopentyl groups on MitoNeo block
intercalation into DNA, we first used a modeling approach that
can be described as manual rigid docking. Starting from the
X-ray structure of a 6-bp double-stranded DNA (d(CGTACG))
containing an acridine-based intercalator (Todd et al., 1999),
we kept the nucleic acid scaffold fixed and manually replaced
the intercalator with E+. Using energy minimization, we opti-
mized the structure and position of the inserted E+. In doing
this, two starting orientations of E+ were considered, obtained
by flipping the molecule by 180, with the substituents on the
central ring sticking out into the major groove. Neo was docked
in the same way, considering again two orientations. As shown
in Figure 5A, E+ easily intercalates, whereas Neo cannot fit in-
between the base pairs, due to the neopentyl groups. Therefore,
Neo cannot insert deep enough between the DNA bases to
allow for favorable p-p stacking interactions, consistent with
the neopentyl groups decreasing the affinity of Neo for DNA
compared with E+.
However, this simple model does not account for the flexibility
of DNA, effects of solvent and salts, or for the influence of the
TPPmoiety of MitoNeo. Therefore we assessed the DNA binding
of Neo and MitoNeo experimentally. To do this, we separated a
DNA ladder by electrophoresis in the presence of Neo and E+
and then measured fluorescence (Figure 5B). This showed
extensive E+ fluorescence associated with theDNA, but no local-
ization of Neo fluorescence in DNA bands, consistent with
negligible intercalation. A similar analysis showed that, while
MitoSOX intercalated into DNA, MitoNeo, MitoNeoOH, and
NeoOH did not (Figure 5C). The intercalation of E+ and of
MitoSOX into DNA increases fluorescence by 20- to 25-fold for
MitoSOX and 7- to 10-fold for E+ (Figures 5D, 5E, and 5F). In
contrast, addition of DNA did not alter MitoNeo or MitoNeoOH
fluorescence (Figures 5D, 5E, and 5F). In summary, the bulky
neopentyl groups of MitoNeo and of its 2-hydroxy derivative
MitoNeoOH prevents their intercalation into DNA.Uptake and Oxidation of MitoNeoD by Mitochondria
and Cells
To serve as a mitochondria-targeted probe, MitoNeoD must be
accumulated bymitochondria in response to themembrane po-
tential. MitoNeoD showed negligible impact on the function of
isolated mitochondria at concentrations below 25 mM (Fig-
ure S6A). To assess uptake qualitatively in isolated mitochon-
dria we first used an electrode responsive to the TPP cation
(Kamo et al., 1979) (Figure 6A). This showed that energization
of mitochondria with the respiratory substrate succinate led to
uptake of MitoNeoH into mitochondria and that abolishing the
membrane potential with the uncoupler carbonyl cyanide 4-(tri-
fluoromethoxy)phenylhydrazone (FCCP) released MitoNeoH
(Figure 6A).
We then assessed the uptake of MitoNeo by mitochondria
within cells, first establishing non-toxic concentrations (Figures
S6B and S6C) and determining how they affected respiration
(Figure S6D). It was not possible to use fluorescencemicroscopy
to measure the uptake of MitoNeoD within cells, because its
fluorescence overlapped with endogenous autofluorescence.
In contrast, the uptake of the highly fluorescent MitoNeo and
MitoNeoOH by cells was readily observed and showed mito-
chondrial localization (Figure 6B). Similar experiments in cells
expressing a mitochondria-targeted GFP (mitoGFP) confirmed
that both MitoNeo and MitoNeoOH localized to mitochondria
(Figure 6C). FCCP decreased the uptake of MitoNeo and
MitoNeoOH into mitochondria (Figure 6D) and led to the slow
release when added after MitoNeo or MitoNeoOH had accumu-
lated for 10 min (Figure S6E).
To see if confocal fluorescence microscopy could differentiate
between the formation of MitoNeoOH andMitoNeo, and thereby
better assess mitochondrial O2
, formation, we measured the
change in fluorescence over time of MitoNeoOH or MitoNeo
incubated with cells, using wavelengths optimized for the detec-
tion of MitoNeoOH (Figure S6F). This showed that there was
enhanced sensitivity to MitoNeoOH over MitoNeo.
We next determined whether MitoNeoD could detect mito-
chondrial O2
, production within cells by confocal fluorescence
microscopy (Figures 6E and 6F). The background rates of
oxidation of MitoNeoH or MitoNeoD by unstressed cells were
low, with MitoNeoD being more stable (Figure 6E, inset).
Increasing O2
, production by the redox cycler menadione
increased mitochondrial fluorescence for both MitoNeoH and
MitoNeoD (Figures 6E and 6F). MitoNeoH was more sensitive
to oxidation by O2
, than MitoNeoD (Figure 6E). However, the
oxidation of MitoNeoD is a more reliable readout of O2
, levels
than MitoNeoH, due to its lower sensitivity to non-specific
oxidation to MitoNeo. MitoNeoD was oxidized by the mitochon-
dria-targeted redox cycler MitoPQ, which generates O2
, by
redox cycling at complex I (Robb et al., 2015) (Figure 6G).
MitoPQ also led to oxidation of MitoSOX Red generating fluo-
rescence that was largely localized to the mitochondria, but
with some labeling of nuclear DNA (Figure 6H). To assess this
further we compared nuclear staining under more oxidizing con-
ditions generated by 5 mMMitoPQ and found that MitoSOX Red
stained most of the nuclei assessed (78% ± 20%, n = 4 inde-
pendent cell fields ± SD) with no staining by MitoNeoD. This is
expected as MitoNeo and its derivatives do not intercalate
into DNA (Figures 5D–5F). We conclude that, while the increaseCell Chemical Biology 24, 1285–1298, October 19, 2017 1291
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Figure 5. Lack of DNA Binding by MitoNeo and Its Derivatives
(A) Models of the intercalation of ethidium (E+, left) and Neo (right) into DNA. The two molecules were docked into a rigid piece of DNA (d(CGTACG)) by manually
replacing the intercalator present in the original X-ray structure and optimizing, starting with different orientations and rotamers for E+ and Neo.
(B) A DNA ladder (10 mg) was mixed with the indicated concentrations of compounds, separated by electrophoresis on an agarose gel and visualized under UV
transillumination.
(C) A DNA ladder was incubated with 10 mM of the indicated compounds, separated and assessed as in (B).
(D and E) Fluorescence emission (D) and excitation (E) spectra in the presence of DNA. MitoNeo, MitoNeoOH,MitoSOX or E+ (50 mM)were dissolved in KCl buffer.
The spectra were measured andmeasured again after addition of 40 mg DNA, and are shown as percentage of the intensity in the absence of DNA. The excitation
and emission wavelengths used were 566 and 636 nm (MitoNeo), 544 and 605 nm (MitoNeoOH), 526 and 605 nm (E+ and MitoSOX), respectively.
(F) Dependence of fluorescence on DNA concentration. The fluorescence intensity of 50 mM of the indicated compounds was measured without DNA and again
after sequential addition of the indicated amounts of DNA. Data are expressed as a percentage of the intensity in the absence of DNA and are a representative
experiment of three replicates.in fluorescence upon oxidation of MitoNeoD is less than that for
MitoSOX Red, it is a more selective indicator of mitochondrial
O2
, formation.1292 Cell Chemical Biology 24, 1285–1298, October 19, 2017Analysis of MitoNeoOH Formation by LC-MS/MS
It should be possible to use MitoNeoD to assess mitochondrial
O2
, formation in vivo by LC-MS/MS, relative to deuterated
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(B) Analysis of cell uptake of MitoNeo andMitoNeoOH by confocal microscopy. C2C12 cells were incubated withMitoNeo or MitoNeoOH (5 mM) as indicated and
the fluorescence determined after 20 min. Scale bar, 20 mm.
(C) Mitochondrial localization of MitoNeo by confocal microscopy. HEK-mitoGFP transgene cells were incubated with MitoNeo or MitoNeoOH (5 mM) for 10 min
and then visualized by confocal microscopy. Scale bars, 10 mm.
(D) Assessment of effect of FCCP on uptake of MitoNeo and MitoNeoOH into cells. Cells were incubated as in (B) in the presence and absence of FCCP, and the
fluorescence in mitochondrial regions quantified four times and the means ± SD are plotted against time.
(legend continued on next page)
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internal standards, as was done for H2O2 by use of themitochon-
dria-targeted mass spectrometric probe MitoB (Cocheme´
et al., 2011). To develop the LC-MS/MS assay we first estab-
lished the fragmentation of MitoNeoOH and MitoNeo, as well
as their deuterated internal standards (Figure 7A). This led to a
sensitive LC-MS/MS assay for these two molecules (Figures
S7A and S7B). The formation of MitoNeoOH from MitoNeoD
when exposed to O2
,was then quantified by LC-MS/MS, which
showed that there was a steady accumulation of MitoNeoOH
that was abolished by adding SOD, and decreased by bubbling
with argon (Figure 7B). Therefore we have established an LC-
MS/MS assay that responds to O2
,.
ToextendMitoNeoDto the in vivoassessmentofO2
,, it is impor-
tant tonormalize the formationofMitoNeoOH to the levelsof itspre-
cursor in vivo (Cocheme´ et al., 2011). This was not possible for
MitoNeoOH as the LC-MS/MS analysis of its precursor MitoNeoD
gave inconsistent results due to variable oxidation upon extraction
and analysis. To overcome this, while still being able to normalize
MitoNeoOH formation, we treated the sample with the hydride
acceptor, chloranil (Zielonka et al., 2006), which oxidizedMitoNeoD
to MitoNeo (Figures S7C–S7E) while leaving MitoNeoOH un-
changed (Figure S7F). Then we measured the amount of
MitoNeoOH and MitoNeo: the amount of MitoNeo thus measured
corresponds to the sum of MitoNeoD and MitoNeo in the sample
at the time of extraction. From this we could determine relative
O2
, formation within a tissue from the amount of MitoNeoOH
formed relative to sum ofMitoNeo andMitoNeoOHmeasured after
reaction with chloranil. We call this sum S MitoNeo3 as it is the
total amount of all MitoNeo variants (MitoNeoD, MitoNeo, and
MitoNeoOH) in the tissue at extraction (Figure 7C). To assess this
in vitrowe exposedMitoNeoD to O2
, and assessed the formation
of MitoNeoOH over time by measuring MitoNeoOH/S MitoNeo3
(Figure 7D). This showed an increase in MitoNeoOH/S MitoNeo3
in the presence of O2
, that was blocked by degrading O2
, by
SOD (Figure 7D). Therefore, the assessment of the MitoNeoOH/S
MitoNeo3 can be used to assess changes in O2
, in vitro.
Assessment of Mitochondrial O2
,– Production In Vivo
Using MitoNeoD
To see if MitoNeoD can assess mitochondrial O2
, formation
in vivo we focused on the mouse heart, because mitochondrial
ROS production has been implicated in a multitude of cardiac
pathologies (Chouchani et al., 2016). The incorporation of the
TPP cation into MitoNeoD should lead to its rapid accumulation
within heart mitochondria following intravenous injection, as has
been shown for other TPP compounds (Porteous et al., 2010).
We assessed this by injecting MitoNeoD into mice intravenously
by a tail vein and then measured MitoNeoOH and MitoNeo in the
heart and expressed this as S MitoNeo3 over time (Figure 7E).
This showed a very rapid uptake of MitoNeoD into the heart
within a few minutes of injection that was then gradually lost(E) Oxidation of MitoNeoH and MitoNeoD in C2C12 cells. The oxidation of MitoN
menadione (men, 500 nM). Data are the means ± SD of four replicates. The back
(F) Oxidation ofMitoNeoD andMitoNeoH inC2C12 cells bymenadione (men). Cell
(0.5 mM). Scale bars, 20 mm.
(G) Oxidation of MitoNeoD in C2C12 cells by MitoPQ. Cells were incubated with
(H) Oxidation of MitoSOX Red in C2C12 cells by MitoPQ. Cells were incubated w
See also Figure S6.
1294 Cell Chemical Biology 24, 1285–1298, October 19, 2017over time, with a half-life of 1 hr, consistent with other TPP
compounds (Porteous et al., 2010). Interestingly, MitoNeoOH
was a small proportion of S MitoNeo3 in the heart, consistent
with low levels of mitochondrial O2
, production in the normoxic
heart and the relative stability of MitoNeoD in vivo (Figure 7E). To
see if MitoNeoOH levels responded to an increase in mitochon-
drial O2
, production in vivo, we administered MitoNeoD to mice
at the same time as MitoPQ, which selectively induces mito-
chondrial O2
, production in the heart (Robb et al., 2015).
MitoPQ increased the MitoNeoOH/S MitoNeo3 ratio markedly
in the hearts (Figure 7F). Therefore, MitoNeoD can be used to
assess mitochondrial O2
, production in vivo.
DISCUSSION
Mitochondrial O2
, production plays a central role in pathology
and redox signaling. However, progress in understanding these
aspects of O2
, physiology has been challenging due to the dif-
ficulties in measuring O2
,. While O2
, assessments work well in
simple systems, in cells O2
, measurement by changes in fluo-
rescence of probes such as HE or MitoSOX Red lacks selectivity
due to non-specific oxidation by other ROS to E+ or MitoSOX
(Zielonka and Kalyanaraman, 2010). Furthermore, fluorescence
is greatly enhanced by intercalation into DNA, potentially distort-
ing fluorescent signaling. As determined by the Kalyanaraman
laboratory, the formation of the 2-hydroxy forms of E+, or of
MitoSOX, are specific for O2
,; however, to assess these 2-hy-
droxy derivatives requires analysis by HPLC. Finally, the mea-
surement of O2
, in vivo is a particular challenge.
To address these issues, here we have developed an
approach that can be used to interrogate mitochondrial O2
,
production in mitochondria, cells, and in vivomodels, using fluo-
rescence, RP-HPLC, and LC-MS/MS. By incorporating neopen-
tyl groups we prevented the intercalation of MitoNeo and
MitoNeoOH into DNA, hence their fluorescence is unaffected
by interactions with DNA. Furthermore, the use of a C-D bond
at a crucial point in the structure of MitoNeoD enhanced its sta-
bility against background oxidation and increased its selectivity
for O2
,. The use of MitoNeoD to assess O2
, production can
also be extended to in vivo situations by the application of LC-
MS/MS to the analysis. This will enable the role of mitochondrial
O2
,metabolism to be assessed in vivo, which is a major unmet
need in the field. While here we have focused on usingMitoNeoD
to assess mitochondrial O2
,, future work will develop NeoD to
measure O2
, elsewhere in the cell.
The development of MitoNeoD is potentially of great use. Even
so, limitations exist. In applying MitoNeoD to assess O2
, in vivo
by LC-MS/MS, a constraint is that each time point requires
destructive tissue extraction ex vivo. A further point is that the
initial radical cation intermediate generated by the oxidation of
MitoNeoD can potentially be formed by other one-electroneoH and MitoNeoD in the absence of added oxidants, or in the presence of
ground levels of oxidation in the absence of oxidants is expanded in the inset.
s were imaged after 20min incubation in the presence or absence ofmenadione
MitoPQ (1 mM) for 20 min. Scale bars, 10 mm.
ith MitoPQ (1 mM) for 20 min. Scale bars, 10 mm.
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Figure 7. LC-MS/MS analysis of O2
,–-Dependent MitoNeoOH Formation In Vitro and In Vivo
(A) Typical LC-MS/MS chromatograms showing the m/z transitions measured simultaneously for 50 nM each of MitoNeo, d15-MitoNeo, MitoNeoOH, and d15-
MitoNeoOH. Traces are normalized to the maximum total ion count for that experiment.
(B) In vitro formation of MitoNeoOH over time. MitoNeoD (20 mM) was incubated with 1 mM HX and 5 mU/mL XO in 250 mL KCl buffer with shaking at 37C
for up to 60 min. The reaction was stopped by the addition of chloranil (10 mL of 10 mM) and incubated with shaking at 37C for 30 min and extracted and
analyzed by LC-MS/MS. Where indicated, the incubations were bubbled with argon, or SOD (20 mg/mL) was added. Data are n = 3 ± SEM for three
incubations.
(C) Schematic of oxidation of MitoNeoD by chloranil, followed by extraction.
(legend continued on next page)
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oxidants as well as O2
, (Figure S1) (Michalski et al., 2014; Rob-
inson et al., 2006; Zielonka and Kalyanaraman, 2010). The selec-
tivity of the generation of MitoNeoOH for O2
, still remains; how-
ever, in theory the formation of MitoNeoOH could be increased
by an elevation in other one-electron oxidants without a change
in O2
, itself. Of course, these limitations also apply to the use
of MitoSOX Red and HE. While fluorescence measurement of
the oxidation of MitoNeoD will still be affected by the parallel
formation of both MitoNeo and MitoNeoOH, the separation of
excitation/emission wavelengths and the greater selectivity of
MitoNeoD for O2
, over other oxidants means that fluorescence
changes in MitoNeoD/NeoD are a more reliable (but not
absolute) indicator of changes in O2
, than HE/MitoSOX Red.
Furthermore, the lack of DNA intercalation of MitoNeo/Neo com-
pounds prevents the dramatic enhancement of E+/MitoSOX fluo-
rescence that may be susceptible to distortion, for example by
changes in amount or accessibility of nuclear or mtDNA.
In summary, we have developed a versatile and robust set of
methodologies to assess changes in mitochondrial O2
, from
isolated mitochondria to animal models in vivo. This develop-
ment should help us better understand the many roles of
mitochondrial O2
, production in health and disease.
SIGNIFICANCE
The measurement of O2
,– is critically important for many as-
pects of biology. However, current approaches are artifact
prone and not applicable in vivo. Here we have developed
a new probe, MitoNeoD, which is accumulated selectively
by mitochondria and there reacts with O2
,– itself to generate
a selective product, MitoNeoOH. This can then be assessed
by fluorescence or by RP-HPLC to assess O2
,– in isolated
mitochondria and in cells. More significantly, the assess-
ment of MitoNeoOH formation from MitoNeoD can also be
done in vivo, which has not been possible previously. This
approach will enable the role of mitochondrial O2
,– forma-
tion in vivo to be analyzed and its role in pathology and cell
signaling determined.
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SEM.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Lines
Mouse C2C12 and human HeLa cells were obtained from American Type Culture Collection (ATCC). Human HEK293T Flp-InTM
T-RexTM were obtained from Invitrogen. All cell lines were cultured in DMEM medium supplemented with 10% fetal bovine serum
(FBS), 100 U/ml penicillin and 100 mg/ml streptomycin, at 37C in an atmosphere of 5% CO2 and 100% humidity.
Mice and Rats
All the procedures were carried out in accordance with the UK Animals (Scientific Procedures) Act 1986 and the University of Cam-
bridge AnimalWelfare Policy. Male C57BL/6 mice were obtained fromCharles Rivers Laboratories (Margate, UK). FemaleWistar rats
were obtained from the Charles River Laboratories (Margate, UK)). Mice and rats were maintained in specific pathogen-free facilities
with ad lib food and water until 8-12 and 10-12 weeks of age, respectively. Animals were killed by stunning and cervical dislocation.
METHOD DETAILS
Chemicals
All reagents were purchased from commercial sources, unless otherwise stated. Neo, NeoOH, MitoNeo, MitoNeoOH and their
deuterated analogues (d5-Neo, d5-NeoOH, d15-MitoNeo and d15-MitoNeoOH) were synthesized as is summarised in Figures 1C
and S2A. Full experimental details and structural assignment are included below. Stock solutions (10 mM) in absolute ethanol
were stored at -20Cwith negligible decomposition observed overmonths. Stock solutions ofMitoNeoH/Dwere prepared as follows:
100 mL MitoNeo (10 mM in EtOH) was placed in a 15 mL Falcon tube, H2O and dichloromethane (CH2Cl2; 200 mL of each) were
added, the tube flushed with argon, then 5 mg NaBH4/NaBD4 (Sigma-Aldrich) were added, the tube closed, followed by vortexing
(5 s). The reaction was easily monitored by the change in color from deep purple (MitoNeo/Neo) to pale green (MitoNeoH/D). Then the
lower organic layer was quickly removed to an argon-flushed Eppendorf, the residual aqueous layer was further extracted (100 mL
CH2Cl2) and the organic layers combined and evaporated under argon. The residue wasweighed and dissolved in EtOH tomake up a
10 mM stock, aliquots of which were evaporated under argon to generate a pale-green solid that was stored at -20C until use. Then
single aliquots were dissolved in absolute EtOH to obtain a 10 mM stock solution that was flushed with argon and stored on ice,
shielded from light and discarded after use. NeoH/D was synthesized from Neo and treated in the same way as MitoNeoH/D.
MitoSOX was prepared from MitoSOX Red (Thermo Fisher Scientific) by oxidation in air.
Optical Measurements
UV-visible absorption was measured using a Shimadzu UV-2501PC spectrophotometer with a thermostatted cuvette holder. Fluo-
rescence spectra were collected at RT in EtOH, in KCl buffer (120 mM KCl, 10 mM HEPES, 1 mM EGTA, pH 7.2 (KOH)) (MitoNeo
series) or KCl buffer supplemented with 20% (v/v) EtOH in a 1 mL cuvette (Neo series) using a Shimadzu RF-5301PC spectrofluor-
ophotometer (Shimadzu Scientific Instruments Inc., Japan). The slit widths were 3 and 5 nm for excitation and emission light, respec-
tively. 3D spectra were collected with excitation and emission light wavelength range 400-780 nm (excitation) and 500-780 (emission)
with 20 nm increment and 1 nm sampling interval. Fluorescence time course measurements were performed in a 3 mL cuvette at
37 C and the excitation and emissionwavelengths were 544 and 605 nm respectively (MitoNeoOH) and 548 and 599 nm respectively
(NeoOH).e2 Cell Chemical Biology 24, 1285–1298.e1–e12, October 19, 2017
O2
,- Generation
The generation of O2
,- was done using 5 mU/mL xanthine oxidase (XO, Sigma-Aldrich), 1 mM hypoxanthine (HX, Sigma-Aldrich) in
KCl buffer (pH 7.2) at 37C. Sustained O2
,- generation was confirmed by the SOD-sensitive reduction of 20 mM ferricytochrome
c (Sigma-Aldrich) at 550 nm ( 3red–ox = 21 mM
-1cm-1), which showed that these conditions reduced ferricytochrome c at an initial
rate of 0.6 mM/min.
Procedure for Docking Ethidium and Neo into DNA
The modelling was done with the program Chimera v. 1.10.2 (Resource for Biocomputing, Visualization, and Informatics at the Uni-
versity of California, San Francisco, http://www.cgl.ucsf.edu/chimera/) (Pettersen et al., 2004), using the Amber ff14SB force field
(Maier et al., 2015) for the nucleic acids and GAFF (Wang et al., 2004) with AM1-BCC charges for the intercalators. Images were pro-
duced with VMD v. 1.9.2 (NIH Center for Biomolecular Modeling and Bioinformatics, http://www.ks.uiuc.edu/Research/vmd/) (Hum-
phrey et al., 1996). In brief, the modelling procedure applied may be described as manual rigid docking. The modelling was based on
the X-ray structure (PDB ID 452D) (Todd et al., 1999) of a 6-bp piece of double-stranded DNA (d(CGTACG)) with a molecule of DACA
intercalating between each of the terminal d(CG) pairs (DACA =N-(2-dimethylamino)ethyl)acridine-4-carboxamide). In the crystal, the
duplexes form chains, with another molecule of DACA bound in-between the d(CG) pairs of adjacent oligomers. This structure was
used as no structure of an oligonucleotide duplex with intercalated ethidium (E+) is available; however, the binding modes of E+ and
DACA are very similar (a structure of E+ bound to a CG duplex is available (Jain and Sobell, 1984). All non-nucleic acid components of
the structure, including DACA, were removed. A pre-optimised molecule of E+ was placed manually in the same position as previ-
ously occupied by an intercalating DACA, with the substituents on the central ring sticking out into themajor groove. Two orientations
of E+ were considered, obtained by flipping the molecule by 180. The structures were optimised, keeping the nucleic acid scaffold
fixed. Neo was docked in the same way, considering again two orientations as well as a rotamer about the Car–N bond that alleviates
the worst clash between the neopentyl group and the backbone.
Pulse Radiolysis
The rate constants for the reaction of O2
,- with both NeoH and MitoNeoH (Reaction 6) were determined by following the formation of
their one-electron oxidised radical spectra in real time upon pulse radiolysis (3 Gy in 200 ns), using the University of Auckland facility
(Anderson et al., 1997). Radical spectra are presented as the changes in absorption per Gy. Due to the poor water solubility of the
compounds, experiments were conducted in water:ethanol solutions (50:50) saturated with air:N2O gas (50:50). Under basic condi-
tions (pH 11) the exclusively formed a-hydroxyethylperoxyl radical (CH3CH(OO
.)OH) quickly breaks down (< 1 ms) upon reaction with
OH- (k5 = 43 10
9 M-1 s-1) to form O2
,- (Bothe et al., 1983) and the rate constant for its reaction with increasing concentrations of the
substrates was monitored at 475 nm. Phosphate buffer, which is also known to speed the breakdown of the a-hydroxyethylperoxyl
radical to O2
,- (Bothe et al., 1983), could not be used as it induced precipitation of the compounds. The reaction of the a-hydroxye-
thylperoxyl radical with the compounds (Reaction 7) was studied in solutions of natural pH (ca. 6.0).H2O ^^^^^/ e
-
aq,
.OH, H., H2O2, H2, H3O
+ (Equation 1)N2O + e
-
aq/
.OH + OH- + N2 (Equation 2).OH/H. + CH3CH2OH/ H2O/H2 + CH3CH(
.)OH (Equation 3)CH3CH(
.)OH + O2/ CH3CH(OO
.)OH (Equation 4)CH3CH(OO
.)OH + OH-/ CH3CHO + O2
.- + H2O (Equation 5)O2
.- + NeoH/MitoNeoH + H2O/ NeoH
+./MitoNeoH+. + HO2
- + OH- (Equation 6)CH3CH(OO
.)OH + NeoH/MitoNeoH/ NeoH+./MitoNeoH+. + CH3CH(OO
-)OH (Equation 7)NeoH+./MitoNeoH+. + H2O! NeoH(-H
+)/MitoNeoH(-H+) + H3O
+ (Equation 8)
Isolation of Rat Liver Mitochondria
Female Wistar rats (Charles River Laboratories) liver mitochondria were isolated by homogenisation and differential centrifugation in
STE buffer (250 mM sucrose, 5 mM Tris, 1 mM EDTA, pH 7.4 (HCl)) at 4 C and stored on ice until use. Protein concentration wasCell Chemical Biology 24, 1285–1298.e1–e12, October 19, 2017 e3
determined by the biuret assay using bovine serum albumin (BSA) as a standard. Mitochondrial incubations at 2 mg protein/mL were
at 37C in KCl buffer (120 mM KCl, 10 mM HEPES, 1 mM EGTA. pH 7.2 (KOH)) unless stated otherwise.
Ion-selective Electrode Measurements
The uptake of MitoNeoH, MitoNeo and MitoNeoOH by energized mitochondria was measured using an ion-selective electrode sen-
sitive to the TPP cation. The electrode was constructed as described previously and the voltage wasmeasured relative to an Ag/AgCl
reference electrode (World Precision Instruments) (Asin-Cayuela et al., 2004; Kamo et al., 1979). The electrodes were connected to a
PowerLab data acquisition system via a front-end pH amplifier and the output was recorded with Chart v. 4.2 software
(ADInstruments, https://www.adinstruments.com/products/labchart). Mitochondria (2 mg protein/mL) were incubated at 37 C in
a stirred thermostatted chamber containing 3 mL KCl buffer and 4 mg/mL rotenone (Sigma-Aldrich). The electrode response was
calibrated by five sequential injections of 1 mM MitoNeoH. Mitochondria were energized with succinate (10 mM) (Sigma-Aldrich)
and uncoupled by addition of 500 nM FCCP (Sigma-Aldrich).
Reverse Phase HPLC Analysis
Samples were dissolved in 1 or 1.5 mL 25 % Buffer B (0.1% (v/v) trifluoroacetic acid (TFA) in acetonitrile (ACN))/75% Buffer A (0.1%
(v/v) TFA in H2O) and filtered (0.22 mmPVDF filter (Millipore)). Sampleswere then loaded via a 2mL injection loop onto aC18RP-HPLC
column (Jupiter 300 A˚, Phenomenex) with aWidepore C18 guard column. Samples were eluted at 2mL/min using a Gilson 321 pump
to generate the following gradient: 5-55% Buffer B 0-4 min; 55-70% Buffer B 4-16 min; 70-100% Buffer B 16-18 min; 100% Buffer
B 18-21 min, 100-5% Buffer B 21-23 min. A220 of column eluent was measured using a Gilson UV/Vis 151 spectrophotometer and
fluorescence (550 nm excitation, 590 nm emission for MitoNeoOH: note these wavelengths are different from those used in aqueous
buffer) was measured using a Shimadzu RF-10AXL fluorescence detector (lexcitation = 328 nm; lemission = 375 nm) connected in series
with the RP-HPLC system described above. Outputs were monitored using Chart v. 4.2 software (ADInstruments, https://www.
adinstruments.com/products/labchart).
Mouse Experiments
Male C57BL/6 mice were administered MitoNeoD (25 nmol) with or without MitoPQ (2.5 nmol) as a 100 mL bolus in 0.9% saline by tail
vein injection and killed at various times subsequently. Hearts were then isolated and frozen in liquid nitrogen. The concentration of
MitoNeoD used (25 nmol/mouse) is lower than the amounts routinely used for iv injection of other TPP compounds such as MitoQ,
which show no toxic effects on mice. There was no observed toxicity in the control mice exposed to MitoNeoD compared to saline
injected controls.
LC-MS/MS Analysis
To analyse MitoNeo compounds in tissues, 50 ± 5mgwet weight tissue was placed in a 2mL Eppendorf tubes and to this was added
248 mL KCl buffer, and 10 mM internal standards (ISs; 5 mM d15-MitoNeoOH/10 mM d15-MitoNeo) and 2 mL chloranil (Sigma-Aldrich)
(10mM in acetone). A spatula was used to add a volume of beadsequivalent to that of the tissue sample (for liver thesewere 0.5mm
diameter zirconium oxide beads and for heart they were 0.9-2.0 mm diameter stainless steel beads, both from Next Advance). The
tissuewas then homogenized in a Bullet Blender (Storm 24(BBY24M) Next Advance) for 3min at speed 10 and then incubated at 37C
for 30min rotating at 1000 rpm (lids closed). For extraction of non-tissue samples the homogenisation step was omitted. The homog-
enate was then supplemented with 1 mL butan-2-ol/methanol (3:1) and sonicated in a water bath (Branson 3800, Bransonic Ultra-
sonic Bath, CPX from Emerson Industrial Automation) at RT for 1 h. The samples were then centrifuged for 10 min at 16,000 x g and
the supernatant was transferred to a fresh 2mL tube and dried in a Speed Vac under vacuum at 40C. To the dried residuewas added
400 mL 40% HPLC grade methanol/0.1% formic acid (FA)/60% HPLC grade water. This was vortexed for 15 min, centrifuged at
16,000 x g for 10 min, the supernatant was vacuum filtered and 300 mL was transferred to mass spectrometry vials and stored at
4C until analysis.
Samples were analysed by LC-MS/MS using an I-class Acquity LC attached to a Xevo TQ-S triple quadrupole mass spectrometer
(Waters), analysed using MassLynx software (Waters, http://www.waters.com/waters/en_US/MassLynx-MS-Software/nav.htm?
locale=en_US&cid=513662). Samples and standards in autosampler vials were placed in a refrigerated holder (4C) while awaiting
introduction by the autosampler. LCwas performed at 30Cusing an Acquity UPLCBEHC18 1.7 mm, 13 50mm (Waters). Themobile
phase consisted of 5% acetonitrile (ACN)/0.1% FA in water (buffer A) and 90%ACN/0.1% FA (buffer B) delivered as a linear gradient:
0-0.3 min, 5% B; 0.3-8 min, 5-100% B; 8-9 min, 100% B; 9-9.1 min, 100-5% B; 9.1-10 min, 5% B. The flow rate was 200 mL/min and
the 2 mL sample volume was introduced via a flow-through needle. An in-line divert valve was used to divert eluent away from the
mass spectrometer from 0-3 min and 7-10 min of the acquisition time. Multiple reaction monitoring (MRM) in positive ion mode
was used to detect the compounds. The instrument parameters were: source spray voltage, 2.7 kV; ion source temperature,
150C; cone voltage and collision energy were optimised for each compound. Nitrogen was used as the curtain gas and argon as
the collision gas. For all experiments, a standard curve was prepared and processed in parallel using the appropriate biological ma-
terial or buffer spikedwith d15-MitoNeo and d15-MitoNeoOH ISs and a range ofMitoNeo orMitoNeoOH amounts. Standard curves for
the response of MitoNeo and MitoNeoOH relative to its deuterated IS against concentration were linear over the range 1-1,000 pmol
with R2 routinely > 0.99.e4 Cell Chemical Biology 24, 1285–1298.e1–e12, October 19, 2017
Analysis of Cell Uptake of MitoNeo Probes by Confocal Microscopy
To assess uptake of MitoNeo and MitoNeoOH into mitochondria within cells, C2C12 cells were seeded at 75,000 cells on 35 mm
diameter glass bottom dish (Ibidi) and allowed to adhere overnight. The medium was removed by aspiration and replaced with Op-
timem, 10% FBS and 1% Glutamax (Invitrogen), containing the different probes ± 0.5 mM FCCP (Sigma-Aldrich). Cells were then
placed on a temperature controlled (37 C) chamber of an inverted microscope (Nikon A1R+) and visualized using a 63X objective
lens (Nikon), 561 nm laser line for excitation and a spectral detector with galvano scanner for acquisition. Images were captured
every min and analyzed using the NIS-Elements software (Nikon, http://www.nikonmetrology.com/en_EU/Products/Software/
Imaging-Software/NIS-Elements-Microscope-Imaging-Software).
To assess the localisation of MitoNeo and MitoNeoOH by confocal microscopy we used the Flp-In T-Rex HEK293T cell line,
which allows for the generation of stable doxycycline-inducible expression of transgenes by FLP recombinase-mediated integration.
Cells were transfected at 50% confluence with the vectors pOG44 and pcDNA5/FRT/TO containing sequence of the genes to be
expressed (mitochodrial-tagged GFP) with slight modification as previously described (Rorbach et al., 2012). 24 h after transfection
the selective antibiotics hygromycin (100 mg/mL, Invitrogen) and blasticidin (15 mg/mL, Invitrogen) were added with selective media.
The day before the experiment cells were grown to 50% confluence on 35 mm diameter glass bottom dish (Ibidi) and induced with
10 mg/mL doxycyclin (Invitrogen) for 24 h to allow the expression of the mitochondria-targeted GFP. On the day of experiment, cells
were incubated withMitoNeo or MitoNeoOH (5 mM) for 10min at 37 C and then visualized on a temperature controlled (37 C) cham-
ber of a Nikon A1R+ inverted confocal microscope using a 63X objective lens (Nikon), 488 and 561 nm laser lines for excitation and a
spectral detector with galvano scanner for acquisition. Images were analyzed using the NIS-Elements software (Nikon). Identical set-
tings were used in comparing images to analyse changes in intensity due to ROS production.
Agarose Gel Electrophoresis
DNA (10 mg of a mixture of a Lambda DNA HindIII digest (NEB) and a PhiX 174 RF DNA HaeIII digest (NEb)) was mixed with the indi-
cated concentrations of compound in DNA loading buffer (2.5% Ficoll-400, 11 mM EDTA, 3.3 mM Tris-HCl, 0.017% SDS, 0.015%
bromophenol blue, pH 8.0). The DNA was then resolved on a 0.9% (w/v) agarose gel in TBE buffer (89 mM Tris, 89 mM borate, 2 mM
EDTA. pH 8.0 (HCl)) for 15-20 min at 400 mA/100 V. The gel was then visualized on a UV transilluminator and photographed with
GeneSnap software (SynGene, http://www.syngene.com/genesnap).
MTS Cell Proliferation Assay
C2C12 cells were seeded in a 96 well plate at 10,000 cells/well, grown overnight and then various concentrations of MitoNeo,
MitoNeoH and MitoNeoOH were added and compared with no additions or ethanol carrier. Menadione (50 M; Md) was used as a
positive control for cell death. After incubation for 17.5 h cell viability was assessed by the MTS assay and the absorbance measured
at 490 nm. Data are means ± SD for 8 wells.
Chemical Syntheses
Synthesis of MitoNeo, Neo and Their Derivatives
The synthesis of MitoNeoH (Figure 1C) began from commercially available 3,8-diaminophenanthridine 1, which underwent double
reductive amination with pivalaldehyde in the presence of sodium triacetoxyborohydride and trifluoroacetic acid (TFA) to give the
bis(neopentyl) derivative 2 in quantitative yield. Selective N-alkylation of the phenanthridine nitrogen atom could be achieved using
freshly prepared 6-bromohexyl triflate 3 to give N-(bromohexyl)phenanthridinium salt 4. Phenanthridines are generally poor nucleo-
philes so the use of an alkyl triflate is preferred (Lee and Shin, 2005; Ross et al., 2000). Fortunately, the neopentyl groups block reac-
tivity on the 3- and 8-amino groups but do not reduce the electron-donating ability of the amino groups, unlike the carbamate
derivatives of 3,8-diaminophenanthridine that are generally used to make N-alkyl phenanthridinum salts. The latter, was partially pu-
rified by chromatography, and then reacted with triphenylphosphine in toluene under reflux to give MitoNeo in moderate yield after
HPLC purification and ion exchange. d15-MitoNeo was prepared from N-(bromohexyl)phenanthridinium salt 4 in the same way using
d15-triphenylphosphine. Reduction of MitoNeo in a two-phase water-dichloromethane mixture under argon by NaBH4/NaBD4 gave
MitoNeoH/D. MitoNeoOH was prepared by reaction of MitoNeo with Fremy’s salt (potassium nitrosodisulfonate) (Zielonka et al.,
2008) and was isolated as a red mesylate salt in modest yield after HPLC and ion exchange. d15-MitoNeoOH was prepared in the
same way. A deuterated form of the dimer of MitoNeo was also prepared to serve as an IS for potential dimer formation (Kalyanara-
man et al., 2014). NeoH andNeoOHwere prepared in a similar way toMitoNeo (Figure S2A). Ethylation of the bis(neopentyl) derivative
2was achievedwith ethyl triflate 5 to give Neo as themesylate salt in good yield after ion exchange. d5-Neowas prepared in the same
way using d5-ethyl triflate 6. Reduction of Neo in a two-phase water-diethyl ether mixture under argon by NaBH4/NaBD4 gave
NeoH/D. The regioselectivity of hydroxylation at C-2 to give MitoNeoOH or NeoOH was confirmed by 1H NMR, as H-7 is shielded
by the ring current of the 6-phenyl group and remains a doublet in MitoNeoOH with a chemical shift similar to that of H-7 in MitoNeo
(5.56 and 6.09 ppm respectively). The same is true for H-7 in NeoOH and Neo (5.91 and 5.81, respectively).
General
All reactions under an inert atmosphere were carried out using oven-dried or flame-dried glassware and solvents were added via
syringe. Reagents were obtained from commercial suppliers and used without further purification. Dry solvents were collected
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from Mg turnings activated with iodine. 1H NMR spectra were obtained using Bruker-Avance III spectrometers operating at 500 and
400 MHz, 13C NMR spectra at 126 and 101 MHz respectively. Signal splitting patterns were described as: singlet (s), doublet (d),
triplet (t), quartet (q), multiplet (m), broad singlet (s, broad), or any combination of the above. All coupling constants were recorded
in Hz. DEPT was used to assign the signals in 13C NMR spectra as C, CH, CH2 and CH3. 2D techniques including COSY, HMBC and
HSQC were used to aid assignment. All spectra were assigned using the following reference solvent peaks for residual non-deuter-
ated solvent in the 1H NMR spectra and for the deuterated solvent in the 13C NMR spectra: CDCl3 (7.26 ppm for
1H NMR; 77.16 ppm
for 13C NMR) CD2Cl2 (5.32 ppm for
1H NMR). 1H NMR analysis of the reaction product of NeoD with O2
, was obtained by exposing
NeoD (100 mM) to O2
, by incubation with XO (0.5 U/mL) and hypoxanthine (1 mM) for 3 h at 37C in 1:0.5:3.5 mixture of EtOH:
PBS:H2O and then extracted into CHCl3, purified by HPLC (see method for NeoOH purification) and the
1H NMR spectrum obtained
as above. HRMS (ESI+) spectra were collected on a Bruker MicroTOF-Q. IR spectra were obtained using Shimadzu FTIR-8400S. Rf
values for phosphonium salts are concentration dependent and are reported as the maximum observed Rf. Purification of products
was carried out by recrystallization, column chromatography using silica gel (70-230mesh) and reverse phase HPLC. Reverse phase
HPLC buffers were 0.1% FA in H2O (Buffer A) and 100% ACN (Buffer B). C18 column (Phenomenex Gemini-NX 10m C18 250 3
21.20 mm) was used. Samples dissolved in 3-5 mL of 25% ACN in 0.1% FA(aq) were filtered manually through a 0.45 mm PTFE filter
(Sartorius Stedim Biotech) and loaded onto a column via a 10 mL injection loop. Samples were eluted at 12 mL/min using different
gradients (SpectraSystem P2000). A220 of the column eluent was detected using UV/Vis spectrophotometer (SpectroMonitor 3200)
and visualized with ChromQuest software.
3,8-Bis(neopentylamino)-6-phenylphenanthridine 2
3,8-Diamino-6-phenylphenanthridine 1 (650 mg, 2.28 mmol, 1.00 eq.) and NaBH(OAc)3 (1.45 g, 6.83 mmol, 3.00 eq.) were mixed in
TFA (0.81 mL, 11 mmol, 4.7 eq.). The mixture was cooled to15C under argon with an IPA/CO2(s) bath. CH2Cl2 (6.5 mL) was added
and the mixture stirred. 2,2-Dimethylpropanal (0.54 mL, 5.0 mmol, 2.2 eq.) was then added by syringe and the mixture allowed to stir
for 2 h, then the mixture was partitioned between CH2Cl2 and H2O, then the aqueous extracted with CH2Cl2. The combined organic
layers werewashedwith brine, then extractedwith CH2Cl2 and the organics combined and solvent removed under reduced pressure.
The material was dissolved in Et2O and precipitated with excess ethereal HCl (2 M), then allowed to settle overnight. The solid was
filtered, washed with Et2O and dissolved in CH2Cl2 then washed with NaHCO3(aq). The aqueous was re-extracted with CH2Cl2, then
the combined organics dried over anhydrous MgSO4, filtered and the solvent removed under reduced pressure to give phenanthri-
dine 2 as a foam (1.08 g, 99%). dH (CDCl3, 500 MHz): 8.28 (1H, d, J = 9.0 Hz, H-10), 8.19 (1H, d, J = 8.9 Hz, H-1), 7.68-7.63 (2H, m,
H-2’’, H-6’’), 7.53-7.43 (3H, m, H-3’’, H-4’’, H-5’’), 7.26 (1H, d, J = 2.3 Hz, H-4), 7.16 (1H, dd, J = 8.9, 2.5 Hz, H-9), 7.02-6.97 (2H, m,
H-7, H-2), 3.91 (2H, apparent s, broad, 3-NHR, 8-NHR), 3.02 (2H, s, 8-NHCH2), 2.87 (2H, s, 3-NHCH2), 1.00 [9H, s, 8-NHCH2C(CH3)3)],
0.96 [9H, s, 3-NHCH2C(CH3)3)]. dC (126 MHz, CDCl3) 159.91 (C), 148.65 (C), 146.73 (C), 143.19 (C), 139.57 (C), 129.51 (CH), 128.56
(CH), 128.25 (CH), 126.56 (C), 125.12 (C), 122.36 (CH), 121.94 (CH), 120.51 (CH), 117.04 (CH), 116.17 (C), 107.43 (CH), 107.33 (CH),
55.88 (CH2), 55.84 (CH2), 32.04 (C), 31.97 (C), 27.58 (CH3), 27.56 (CH3). IR (ATR cm
-1): 3424 (N-H), 3285 (N-H), 2953 (C-H), 2864 (C-H),
1620 (C=N), 1568 (CAr=CAr), 1512 (CAr=CAr). MS (EI
+): 425 (M+,, 72%), 368 [M+, –.C(CH3)3, 100]. HRMS: 425.2837. C29H35N3 requires
requires M+,, 425.2831.
6-Bromohexyl Trifluoromethanesulfonate 3
1-Bromohexan-6-ol (0.72 mL, 5.5 mmol, 1.0 eq.) was added to a stirring solution of anhydrous CH2Cl2 (5 mL), anhydrous pyridine
(0.40 mL, 5.0 mmol, 0.9 eq.) and triflic anhydride (1.0 mL, 6.1 mmol, 1.1 eq.) at 0C under argon. The mixture was allowed to stir
at 0C for 1.5 h and quenched into CH2Cl2/H2O (50 mL). The layers were separated and organics were washed with H2O (2 3
30 mL), dried over anhydrous MgSO4, filtered and concentrated under reduced pressure to give triflate 3 as a pure yellow-brown
oil (1.53 g, 88%). dH (400MHz, CDCl3): 4.55 (2H, t, J = 5.9 Hz, CH2OTf), 3.40 (2H, t, J = 6.9 Hz, CH2Br), 1.91-1.80 (4H, m,CH2CH2OTf,
CH2CH2Br), 1.55-1.40 (4H, m, RCH2CH2R’). dC (101MHz, CDCl3): 118.6 (q, J = 320.6 Hz, CF3), 77.62 (CH2), 33.40 (CH2), 32.29 (CH2),
29.01 (CH2), 27.28 (CH2), 24.22 (CH2).
1H and 13C NMR data agree with literature.(Armstrong-Chong et al., 2004)
3,8-Bis(neopentylamino)-5-(6’-bromohexyl)-6-phenylphenanthridinium Triflate 4
Phenanthridine 2 (1.00 g, 2.35 mmol, 1.0 eq.) was added to a stirring solution of triflate 3 (750 mg, 2.40 mmol, 1.0 eq.) in anhydrous
Et2O (12.5 mL) at –30
C under argon. The mixture was allowed to warm to RT and stirred over 16 h. The reaction was quenched into
H2O (50 mL), extracted with CH2Cl2 (50mL), the organic layer separated and dried over anhydrousMgSO4, filtered and concentrated
under reduced pressure to give a purple foam. Column chromatography [SiO2, gradient from CH2Cl2-NEt3-ACN (91.5:1:7.5) to
(83:2:15)] yielded triflate 4 as a purple glassy foam (990 mg, 52% approx. 85% pure). Rf [SiO2, CH2Cl2-NEt3-ACN (91.5:1:7.5)]:
0.22. dH (400 MHz, CDCl3): 8.30 (1H, d, J = 9.3 Hz, H-10), 8.15 (1H, d, J = 9.3 Hz, H-1), 7.82-7.73 (3H, m, Ph). 7.55 (1H, dd, J =
9.0, 2.2 Hz, H-9), 7.47 (1H, apparent s, broad, H-4), 7.43-7.38 (3H, m, Ph, H-2), 6.30 (1H, t, J = 5.9 Hz, 3-NHR), 6.04 (1H, d, J =
2.3 Hz, H-7), 4.83 (1H, t, J = 6.1 Hz, 8-NHR), 4.63 (2H, m, NCH2), 3.35 (2H, t, J = 6.6 Hz, CH2Br), 3.14 (2H, d, J = 5.8 Hz, 3-NHCH2tBu),
2.67 (2H, d, J = 5.6 Hz, 8-NHCH2tBu), 1.96-1.85 (2H, m, CH2-2’), 1.81-1.73 (2H, m, CH2-5’), 1.39-1.27 (4H, m, CH2-3’, CH2-4’), 1.09
(9H, s, 3-NHCH2tBu), 0.89 (9H, s, 8-NHCH2tBu). dC (101 MHz, CDCl3): 157.03 (C), 152.14 (C), 147.90 (C), 134.97 (C), 132.08 (C),
131.14 (CH), 129.69 (CH), 128.81 (C), 128.67 (CH), 128.19 (CH), 124.71 (C), 124.13 (CH), 121.89 (CH), 118.20 (CH), 117.47 (C),
104.32 (CH), 97.42 (CH), 55.04 (CH2), 54.79 (CH2), 53.42 (CH2), 33.78 (CH2), 32.78 (C), 32.47 (C), 32.16 (CH2), 28.88 (CH2), 27.66
(CH3), 27.56 (CH3), 27.22 (CH2), 25.36 (CH2). nMax(ATR)cm
-1: 3362 (N-H), 2949 (C-H), 2933 (C-H), 2862 (C-H), 1618 (C=N). MS
(ESI+): 588 [M+ (79Br, phenanthridinium cation), 100%] and 590 [M+ (81Br, phenanthridinium cation), 100%]. HRMS: 588.2926 and
590.2913. C35H47
79BrN3
+ requires M+, 588.2948 and C35H47
81BrN3
+ requires M+, 590.2928.e6 Cell Chemical Biology 24, 1285–1298.e1–e12, October 19, 2017
3,8-Bis(neopentylamino)-5-(6’-triphenylphosphoniohexyl)-6-phenylphenanthridinium Mesylate (MitoNeo, Bis-
mesylate Salt)
6’-Bromohexylphenanthridinium triflate 4 (200 mg, 0.27 mmol, 1.0 eq.) was combined with triphenylphosphine (360 mg, 1.37 mmol,
5.0 eq.), the mixture was dried by azeotrope with anhydrous toluene (2.0 mL). This was repeated one more time and after removal of
the solvent under reduced pressure anhydrous toluene (2.5 mL) was added to the mixture. The resulting solution was stirred for 24 h
at reflux under argon. The mixture was allowed to cool to RT, the toluene removed with a pipette, the residue washed with toluene,
dissolved in CHCl3 and concentrated under reduced pressure to give a purple solid. The crudemixture was purified using preparative
HPLCmethod by separate injections of 15mg crude for each purification. Gradient elution of buffers A and Bwas from 75:25 to 60:40
over 40 min and from 60:40 to 55:45 over the next 20 min. Pure fractions were collected and combined. Brine was added (addition of
brine helps to extract aqueous layer containing ACN), the solution was extracted with CHCl3, dried over anhydrous MgSO4, filtered
and concentrated under reduced pressure to give MitoNeo as a chloride salt. The solid was ion exchanged to the mesylate form [IRA
401 resin in mesylate form, loaded and eluted in MeOH-H2O (1:1)], furnishing mesylate MitoNeo as a purple glass (120mg, 46%). tR =
29min. dH (500 MHz, CDCl3): 8.38 (1H, d, J = 9.3 Hz, H-1), 8.26 (1H, d, J = 9.3 Hz, H-10), 7.99 (1H, d, J = 2.1 Hz, H-4), 7.81-7.60 (19H,
m, C-6-Ph, PPh3, H-9), 7.39-7.29 (3H, m, C-6-Ph, H-2), 6.09 (1H, d, J = 2.4 Hz, H-7), 4.70 (2H, apparent s, broad, CH2-1’), 3.58-3.42
(2H, m, CH2-6’), 3.10 (2H, s, 3-NHCH2
tBu), 2.74 (6H, s, 2CH3SO3
-), 2.67 (2H, s, 8-NHCH2
tBu), 1.85 (2H, apparent s, broad, CH2-2’),
1.55 (6H, apparent s, broad, CH2-3’, CH2-4’, CH2-5’), 1.03 (9H, s, 3-NHCH2
tBu), 0.86 (9H, s, 8-NHCH2
tBu). dC (126 MHz, CDCl3):
157.23 (C), 152.67 (C), 148.30 (C), 135.06 (d, J = 2.9 Hz, CH), 134.95 (C), 133.67 (d, J = 10.0 Hz, CH), 132.30 (C), 131.06 (CH),
130.54 (d, J = 12.5 Hz, CH), 129.72 (CH), 129.28 (CH), 128.89 (C), 128.09 (CH), 124.71 (C), 124.29 (CH), 121.87 (CH), 118.53 (d,
J = 85.9 Hz, C), 117.24 (C), 116.23 (CH), 104.30 (CH), 99.73 (CH), 55.26 (CH2), 54.92 (CH2), 53.43 (CH2), 39.73 (CH3), 32.88 (C),
32.67 (C), 29.22 (CH2), 29.09 (CH2), 27.80 (CH3), 27.73 (CH3), 24.88 (CH2), 21.94 (d, J = 4.3 Hz, CH2), 21.38 (d, J = 51.0 Hz, CH2).
HRMS (ESI+, m/z): found 385.7327. C53H62N3P (M
2+, phenanthridinium dication) requires 385.7335. 1H and 13C NMR and HRMS
data agree (Cairns et al., 2014).
3,8-Bis(neopentylamino)-5-[6’-tri(pentadeuterophenyl)phosphoniohexyl]-6-phenylphenanthridinium Mesylate (d15-
MitoNeo, Bis-mesylate Salt)
6’-Bromohexylphenanthridinium triflate 4 (146 mg, 0.20 mmol, 1.0 eq.) was combined with tri(pentadeuterophenyl)phosphine
(277 mg, 0.99 mmol, 5.0 eq.), the mixture was dried by azeotrope with anhydrous toluene (2.0 mL). This was repeated one more
time and after removal of the solvent under reduced pressure anhydrous toluene (2.0 mL) was added to the mixture. The resulting
solution was stirred for 24 h at reflux under argon. The mixture was allowed to cool to RT, the toluene removed with a pipette, the
residue washed with toluene, dissolved in CHCl3 and concentrated under reduced pressure to give a purple solid. The crude solid
was purified using preparative HPLCmethod by separate injections of 15mg crude for each purification. Gradient elution of buffers A
andBwas from 75:25 to 60:40 over 40min and from 60:40 to 55:45 over the next 20min. Pure fractions were collected and combined.
Brine was added, the solution was extracted with CHCl3, dried over anhydrous MgSO4, filtered and concentrated under reduced
pressure to give d15-MitoNeo as a chloride salt. The solid was ion exchanged to the mesylate form [IRA 401 resin in mesylate
form, loaded and eluted in MeOH-H2O (1:1)], furnishing mesylate d15-MitoNeo as a purple glass (92 mg, 47%). tR = 29 min. dH
(500 MHz, CDCl3): 8.32 (1H, d, J = 9.3 Hz, H-1), 8.19 (1H, d, J = 9.2 Hz, H-10), 7.94 (1H, s, H-4), 7.71-7.63 (4H, m, C-6-Ph, H-9),
7.33-7.27 (3H, m, C-6-Ph, H-2), 7.06 (1H, apparent s, broad, 3-NHR), 5.95 (1H, d, J = 2.4 Hz, H-7), 5.23 (1H, apparent s, broad,
8-NHR), 4.76-4.58 (2H, m, CH2-1’), 3.59-3.45 (2H, m, CH2-6’), 3.07 (2H, s, 3-NHCH2
tBu), 2.69 (6H, s, 2CH3SO3
-), 2.62 (2H, s,
8-NHCH2
tBu), 1.83 (2H, apparent s, broad, CH2-2’), 1.62-1.45 (6H, m, CH2-3’, CH2-4’, CH2-5’), 1.01 (9H, s, 3-NHCH2
tBu), 0.82
(9H, s, 8-NHCH2
tBu). dC (126 MHz, CDCl3): 157.33 (C), 152.72 (C), 148.23 (C), 135.00 (C), 134.98-134.30 (m, CD), 133.72-132.83
(m, CD), 132.30 (C), 131.10 (CH), 130.35-129.90 (m, CD), 129.75 (CH), 129.13 (CH), 128.95 (C), 128.11 (CH), 124.73 (C), 124.31
(CH), 121.94 (CH), 118.35 (d, J = 85.7 Hz, C), 117.24 (C), 116.20 (CH), 104.51 (CH), 99.86 (CH), 55.28 (CH2), 54.96 (CH2), 53.48
(CH2), 39.74 (CH3), 32.91 (C), 32.66 (C), 29.26 (CH2), 29.11 (CH2), 27.82 (CH3), 27.74 (CH3), 24.91 (CH2), 21.94 (d, J = 4.7 Hz,
CH2), 21.39 (d, J = 51.4 Hz, CH2). IR nmax(cm
-1): 3352 (N-H), 3240 (N-H), 3056 (CAr-H), 2951 (C-H), 2866 (C-H), 1619 (C=N), 1476
(CAr=CAr). HRMS (ESI
+, m/z): found 393.2787. C53H47D15N3P (M
2+, phenanthridinium dication) requires 393.2806.
3,8-Bis(neopentylamino)-5-(6’-triphenylphosphoniohexyl)-6-phenylphenanthridine (MitoNeoH) and
3,8-Bis(neopentylamino)-5-(6’-triphenylphosphoniohexyl)-6-deutero-6-phenylphenanthridine (MitoNeoD)
MitoNeo (bis-mesylate salt, 30 mg, 0.03 mmol, 1.0 eq.) was added to a tube flushed with argon and filled with 3.0 mL of degassed
H2O, 3.0 mL of degassed CH2Cl2 and shaken to dissolve under argon. NaBH4 (12 mg, 0.32 mmol, 10 eq.) was added afterwards and
the mixture was shaken for 5 min under argon in the dark and the phases were left to separate for 1 min. The organic layer was sy-
ringed out to a vial flushed with argon; the aqueous layer was extracted again with 3.0 mL of degassed CH2Cl2 and the organic layer
was syringed out to a vial. The organics were combined and the solvent was evaporated by argon flux furnishingMitoNeoH as a pale
green foam (24 mg, 99%). The crude was used without purification in the next step. An identical result was obtained when MitoNeo
was reduced with NaBD4 to give MitoNeoD. UV-visible and HPLC data are given in the main text. MitoNeoH/D are air-sensitive so
NMRdatawere obtained in a separate experiment in which 4mg ofMitoNeowas dissolved in 0.6mL of CD2Cl2, placed under argon in
an NMR tube and a solution of 1 mg of NaBH4/NaBD4 in 0.7 mL of D2O was added, the tube was shaken until the purple colour
disappeared and the NMR spectra were obtained. The two distinct spins systems in MitoNeo-H were assigned by COSY while
the H1-H2-H4 spin systemwas assigned to themore upfield protons. Note: H2O and CH2Cl2 (10mL each) should be degassed sepa-
rately in flasks with Suba-Seals by bubbling the contents of a large argon-filled balloon through a long needle with a vent presentCell Chemical Biology 24, 1285–1298.e1–e12, October 19, 2017 e7
(10-15 min) and kept under argon. All reaction vessels (tubes, vials) should be kept under positive argon pressure; all the needles and
syringes should be flushed with argon before use. All the manipulations with a reduced product should be done in the dark.
MitoNeoH. dH (400MHz, CD2Cl2): 7.91-7.76 (3H, m, PPh3), 7.76-7.63 (6H, m, PPh3), 7.65-7.51 (6H, m, PPh3), 7.36 (1H, d, J = 8.3 Hz,
H-1), 7.33 (1H, d, J = 8.3 Hz, H-10), 7.18-7.12 (5H,m, C-6-Ph), 6.50 (1H, dd, J = 8.4, 2.3 Hz, H-9), 6.37 (1H, d, J = 2.4 Hz, H-7), 6.09 (1H,
dd, J = 8.2, 2.2 Hz, H-2), 5.95 (1H, d, J = 2.2 Hz, H-4), 5.23 (1H, s, H-6), 3.51-3.37 (1H, m, NCHACHB), 3.12-2.94 (3H, m, NCHACHB,
PCH2), 2.88 (2H, s, NCH2), 2.83 (2H, s, NCH2), 1.70-1.58 (6H,m, 33CH2), 1.44-1.34 (2H,m, CH2), 0.98 (9H, s, NHCH2
tBu), 0.96 (9H, s,
NHCH2
tBu).
dC (101 MHz, CD2Cl2): 149.95 (C), 147.87 (C), 144.56 (C), 143.95 (C), 135.88 (d, J = 3.1 Hz, CH), 135.77 (C), 133.95 (d, J = 9.9 Hz,
CH), 131.12 (d, J = 12.5 Hz, CH), 128.89 (CH), 127.72 (CH), 127.06 (CH), 123.57 (CH), 122.83 (CH), 121.39 (C), 118.35 (d, J = 86.3 Hz,
C), 113.62 (C), 113.12 (CH), 110.70 (CH), 102.64 (CH), 97.61 (CH), 66.92 (CH), 56.44 (CH2), 56.37 (CH2), 49.69 (CH2), 32.29 (C), 32.21
(C), 30.61 (d, J = 15.6 Hz, CH2), 28.01 (CH3), 27.93 (CH3), 27.18 (CH2), 26.84 (CH2), 22.95 (d, J = 51.5 Hz, CH2), 22.75 (d, J =
4.7 Hz, CH2).
MitoNeoD. dH (400 MHz, CD2Cl2): 7.88-7.80 (3H, m, PPh3), 7.72-7.65 (6H, m, PPh3), 7.60-7.53 (6H, m, PPh3), 7.36 (1H, broad d, J =
8.3 Hz, H-1), 7.33 (1H, broad d, J = 8.7 Hz, H-10), 7.17-7.11 (5H, m, C-6-Ph), 6.49 (1H, broad d, J = 8.7 Hz, H-9), 6.37 (1H, broad s,
H-7), 6.09 (1H, broad d, J = 8.3 Hz, H-2), 5.95 (1H, broad s, H-4), 3.43 (1H, dd, J = 13.9, 7.0 Hz, NCHACHB), 3.11-2.92 (3H, m,
NCHACHB, PCH2), 2.88 (2H, s, NCH2), 2.83 (2H, s, NCH2), 1.70-1.58 (6H,m, 33CH2), 1.44-1.34 (2H,m, CH2), 0.98 (9H, s, NHCH2
tBu),
0.96 (9H, s, NHCH2
tBu).
3,8-Bis(neopentylamino)-5-(6’-tri(pentadeuterophenyl)phosphoniohexyl)-6-phenylphenanthridine (d15-MitoNeoH)
d15-MitoNeo (bis-mesylate salt, 30 mg, 0.03 mmol, 1.0 eq.) was added to a tube flushed with argon and filled with 3.0 mL of de-
gassed H2O, 3.0 mL of degassed CH2Cl2 and shaken to dissolve under argon. NaBH4 (12 mg, 0.31 mmol, 10 eq.) was added after-
wards and the mixture was shaken for 5 min under argon in the dark and the phases were left to separate for 1 min. The organic layer
was syringed out to a vial flushed with argon; the aqueous layer was extracted again with 3.0 mL of degassed CH2Cl2 and the organic
layer was syringed out to a vial. The organics were combined and the solvent was evaporated by argon flux furnishing d15-MitoNeoH
as a pale green foam (24 mg, 99%). The crude was used without purification in the next step. N.B. The same precautions apply as for
MitoNeoH.
d15-MitoNeoH/D are air-sensitive so NMR data were obtained in a separate experiment in which 8 mg d15-MitoNeo was dissolved
in 0.6 mL of CD2Cl2, placed under argon in an NMR tube and a solution of1.2 mg of NaBH4/NaBD4 in 0.7 mL of D2Owas added, the
tube was shaken until the purple colour disappeared and the NMR spectra were obtained. Similarly, d15-MitoNeoD was synthesised
from 15mg d15-MitoNeo and 2.4 mg NaBD4. The two distinct spins systems in MitoNeo-H were assigned by COSYwhile the H1-H2-
H4 spin system was assigned to the more upfield protons. Note: H2O and CH2Cl2 (10 mL each) should be degassed separately in
flasks with Suba-Seals by bubbling the contents of a large argon-filled balloon through a long needle with a vent present
(10-15 min) and kept under argon. All reaction vessels (tubes, vials) should be kept under positive argon pressure; all the needles
and syringes should be flushed with argon before use. All the manipulations with a reduced product should be done in the dark.
d15-MitoNeoH. dH (400MHz, CD2Cl2): 7.36 (1H, d, J = 8.3 Hz, H-1), 7.33 (1H, d, J = 8.5 Hz, H-10), 7.17-7.12 (5H,m, Ph), 6.50 (1H, dd,
J = 8.5, 2.4 Hz, H-9), 6.37 (1H, d, J = 2.5 Hz, H-7), 6.09 (1H, dd, J = 8.3, 2.1 Hz, H-2), 5.94 (1H, d, J = 2.3 Hz, H-4), 5.23 (1H, s, H-6),
3.48-3.39 (1H, m, NCHACHB), 3.08-3.01 (1H, m, NCHACHB, PCH2), 3.00-2.93 (2H, m, PCH2), 2.88 (2H, s, NCH2), 2.83 (2H, s, NCH2),
1.70-1.46 (6H, m, 33 CH2), 1.43-1.34 (2H, m, CH2), 0.98 (9H, s, NHCH2
tBu), 0.96 (9H, s, NHCH2
tBu). dC (101 MHz, CD2Cl2): 149.93
(C), 147.83 (C), 144.55 (C), 143.93 (C), 135.76 (C), 135.73-135.10 (m, CD), 133.83-133.25 (m, CD), 130.96-130.26 (m, CD), 128.88
(CH), 127.72 (CH), 127.04 (CH), 123.55 (CH), 122.82 (CH), 121.36 (C), 118.10 (d, J = 86.1 Hz, C), 113.6 (C), 113.10 (CH), 110.69
(CH), 102.62 (CH), 97.58 (CH), 66.91 (CH), 56.42 (CH2), 56.35 (CH2), 49.67 (CH2), 32.27 (C), 32.20 (C), 30.65 (d, J = 15.6 Hz, CH2),
27.99 (CH3), 27.92 (CH3), 27.17 (CH2), 26.82 (CH2), 22.95 (d, J = 51.5 Hz, CH2), 22.75 (d, J = 4.7 Hz, CH2).
d15-MitoNeoD. dH (400MHz, CD2Cl2): 7.36 (1H, d, J = 8.3 Hz, H-1), 7.33 (1H, d, J = 8.5 Hz, H-10), 7.17-7.11 (5H,m, Ph), 6.50 (1H, dd,
J = 8.5, 2.5 Hz, H-9), 6.37 (1H, d, J = 2.5 Hz, H-7), 6.09 (1H, dd, J = 8.3, 2.2 Hz, H-2), 5.95 (1H, d, J = 2.2 Hz, H-4), 3.43 (1H, dd, J = 13.4,
6.2 Hz, NCHACHB), 3.10-2.92 (3H,m, NCHACHB, PCH2), 2.88 (2H, s, NCH2), 2.83 (2H, s, NCH2), 1.70-1.48 (6H,m, 33CH2), 1.44-1.33
(2H, m, CH2), 0.98 (9H, s, NHCH2
tBu), 0.96 (9H, s, NHCH2
tBu). dC (101 MHz, CD2Cl2): 149.93 (C), 147.83 (C), 144.55 (C), 143.88 (C),
135.70 (C), 135.66-135.03 (m, CD), 134.05-132.97 (m, CD), 131.14-130.14 (m, CD), 128.87 (CH), 127.70 (CH), 127.03 (CH), 123.53
(CH), 122.81 (CH), 121.35 (C), 118.11 (d, J = 86.1 Hz, C), 113.59 (C), 113.07 (CH), 110.63 (CH), 102.58 (CH), 97.57 (CH), 56.41
(CH2), 56.34 (CH2), 49.60 (CH2), 32.27 (C), 32.19 (C), 30.63 (d, J = 15.8 Hz, CH2), 27.98 (CH3), 27.91 (CH3), 27.18 (CH2), 26.81
(CH2), 22.90 (d, J = 51.5 Hz, CH2), 22.75 (d, J = 4.4 Hz, CH2). Note: C-6 C-D not resolved from baseline.
3,8-Bis(neopentylamino)-2-hydroxy-5-(6’-triphenylphosphoniohexyl)-6-phenylphenanthridinium Mesylate
(MitoNeoOH, Bis-mesylate Salt)
Fremy’s salt (27 mg, 0.10 mmol, 4.0 eq.) was dissolved in 20 mL of phosphate buffer (pH 7.4), through which argon was bubbled
during 10 min prior to salt addition. Freshly prepared MitoNeoH (20 mg, 0.03 mmol, 1.0 eq.), which was used immediately after
the synthesis, was dissolved in 0.5 mL of CH2Cl2, transferred to the buffer and the mixture was stirred at RT under argon for 1 h
in the dark. The solution was extracted with CHCl3 (3 3 20 mL), the organic layers combined, dried over anhydrous MgSO4, filtered
and concentrated under reduced pressure to give a raspberry red foam. The crude foam was purified using preparative HPLC
method by separate injections of 10 mg crude for each purification. Gradient elution of buffers A and B was from 75:25 to 65:35
over 40min and from 65:35 to 58:42 over the next 20min. Pure fractions were collected and combined. Brine was added, the solutione8 Cell Chemical Biology 24, 1285–1298.e1–e12, October 19, 2017
was extracted with CHCl3, dried over anhydrousMgSO4, filtered and concentrated under reduced pressure to giveMitoNeoOH as a
chloride salt. The solid was ion exchanged to the mesylate form [IRA 401 resin in mesylate form, loaded and eluted in MeOH-H2O
(1:1)], furnishing mesylate MitoNeoOH as a raspberry red glass (7 mg, 28%). tR = 28 min. dH (500 MHz, CDCl3): 11.76 (1H, s,
OH), 8.52 (1H, d, J = 9.3 Hz, H-10), 8.44 (1H, s, H-1), 7.88-7.63 (18H, m, PPh3, C-6-Ph), 7.52 (1H, dd, J = 9.1, 2.3 Hz, H-9),
7.24-7.16 (2H, m, C-6-Ph), 6.65 (1H, s, H-4), 5.86 (1H, d, J = 2.3 Hz, H-7), 5.27 (1H, t, J = 5.1 Hz, 3-NHR), 4.90 (1H, apparent s, broad,
8-NHR), 4.49 (2H, apparent s, broad, CH2-1’), 3.75-3.49 (2H, m, CH2-6’), 3.05 (2H, d, J = 5.1 Hz, 3-NHCH2
tBu), 2.75 (6H, s,
2CH3SO3
-), 2.63 (2H, s, 8-NHCH2
tBu), 1.75 (2H, apparent s, broad, CH2-2’), 1.67-1.51 (4H, m, CH2-3’, CH2-5’), 1.49-1.33 (2H, m,
CH2-4’), 0.99 (9H, s, 3-NHCH2
tBu), 0.84 (9H, s, 8-NHCH2
tBu). HRMS (ESI+, m/z): found 393.7299. C53H62N3OP (M
2+, phenanthridi-
nium dication) requires 393.7310.
3,8-bis(neopentylamino)-2-hydroxy-5-(6’-tri(pentadeuterophenyl)phosphoniohexyl)-6-phenylphenanthridinium
Mesylate (d15-MitoNeoOH, Bis-mesylate Salt)
Fremy’s salt (27 mg, 0.10 mmol, 4.0 eq.) was dissolved in 20 mL of phosphate buffer (pH 7.4), through which argon was bubbled
during 10 min prior to salt addition. Freshly prepared d15-MitoNeoH (20 mg, 0.03 mmol, 1.0 eq.), which was used immediately after
the synthesis, was dissolved in 0.5 mL of CH2Cl2, transferred to the buffer and the mixture was stirred at RT under argon for 1 h in the
dark. The solution was extracted with CHCl3 (33 20 mL), the organic layers combined, dried over MgSO4, filtered and concentrated
under reduced pressure to give a raspberry red foam. The crude mixture was purified using preparative HPLC method by separate
injections of 10mg crude for each purification. Gradient elution of buffers A andBwas from 75:25 to 65:35 over 40min and from 65:35
to 58:42 over the next 20 min. Pure fractions were collected and combined. Brine was added, the solution was extracted with CHCl3,
dried over anhydrousMgSO4, filtered and concentrated under reduced pressure to give d15-MitoNeoOH as a chloride salt. The solid
was ion exchanged to the mesylate form [IRA 401 resin in mesylate form, loaded and eluted in MeOH-H2O (1:1)], furnishingmesylate
d15-MitoNeoOH as a raspberry red glass (7 mg, 28%). tR = 28 min. dH (500 MHz, CDCl3): 11.81 (1H, s, OH), 8.52 (1H, d, J = 9.2 Hz,
H-10), 8.47 (1H, s, H-1), 7.68-7.62 (3H, m, Ph), 7.52 (1H, dd, J = 9.3, 2.4 Hz, H-9), 7.24-7.17 (2H, m, Ph), 6.66 (1H, s, H-4), 5.87 (1H, d,
J = 2.4 Hz, H-7), 5.30 (1H, apparent s, broad, 3-NHR), 4.88 (1H, apparent s, broad, 8-NHR), 4.48 (2H, apparent s, broad, CH2-1’),
3.71-3.60 (2H, m, CH2-6’), 3.05 (2H, d, J = 5.4 Hz, 3-NHCH2
tBu), 2.75 (6H, s, 2CH3SO3
-), 2.64 (2H, d, J = 3.5 Hz, 8-NHCH2
tBu),
1.78 (2H, apparent s, broad, CH2-3’), 1.69-1.50 (4H, m, CH2-3’, CH2-5’), 1.45-1.35 (2H, m, CH2-4’), 0.99 (9H, s, 3-NHCH2
tBu),
0.84 (9H, s, 8-NHCH2
tBu). HRMS (ESI+, m/z): found 401.2762. C53H47D15N3OP (M
2+, phenanthridinium dication) requires 401.2781.
Ethyl Trifluoromethanesulfonate 5
Purchased from commercial supplier and used as supplied.
Pentadeuteroethyl Trifluoromethanesulfonate 6
Triflic anhydride (3.60 mL, 21.1 mmol, 1.1 eq.) was dissolved in anhydrous CH2Cl2 (15 mL) and stirred at 0
C under argon for 5 min.
Anhydrous pyridine (1.60 mL, 19.2 mmol, 1.0 eq.) and anhydrous pentadeuteroethanol (1.00 g, 19.2 mmol, 1.0 eq.) were dissolved in
anhydrous CH2Cl2 (10 mL) and added dropwise to the solution of triflic anhydride. The mixture was stirred at 0
C under argon for
25 min. Then the solution was quickly washed with H2O (15 mL), dried over anhydrous MgSO4, filtered and 15-20 mL of solvent
were evaporated under reduced pressure with no heating. The crude in residual organics (5-10 mL) was distilled to furnish 6 as a
transparent liquid (1.10 g, 32%); bp 110-115C. dC (126 MHz, CDCl3): 118.97 (q, J = 320.0 Hz, C), 74.40-73.25 (m, CD2),
15.13-13.72 (m, CD3). The compound is known in the literature but not characterized (Anderson and Harruna, 1987). Chemical shifts
in 13C NMR are close to those reported for ethyl triflate (Shima et al., 1996).
3,8-Bis(neopentylamino)-5-ethyl-6-phenylphenanthridinium Mesylate (Neo Mesylate)
Phenylphenanthridine 2 (400 mg, 0.94 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (4.0 mL) and stirred at 0
C under argon.
Ethyl triflate 5 (0.98 mL, 0.75 mmol, 0.8 eq.) was added followed by a further addition of CH2Cl2 (1.0 mL). The ice bath was removed
and the solution was stirred for 15 h at RT under argon. Themixture was washed with H2O (10 mL), the organic layer separated, dried
over anhydrous MgSO4, filtered and concentrated under reduced pressure to give a purple foam. The residue was loaded on a silica
plug (50 g), washed with Et2O (83 100 mL), eluted with CHCl3 and the solvent was concentrated under reduced pressure. The res-
idue was purified using preparative HPLC method by separate injections of 15 mg of crude for each purification. Gradient elution of
buffers A and Bwas from 60:40 to 45:55 over 45min. Pure fractions were collected and combined. Brine was added, the solution was
extracted with CHCl3, dried over anhydrousMgSO4, filtered and concentrated under reduced pressure to giveNeo as a chloride salt.
The solid was ion exchanged to the mesylate form [IRA 401 resin in mesylate form, loaded and eluted in MeOH-H2O (1:1)], furnishing
Neo mesylate as a purple foam (252 mg, 49%). tR = 20 min.
dH (500 MHz, CDCl3): 8.03 (1H, d, J = 9.3 Hz, H-1), 7.77 (1H, d, J = 9.3 Hz, H-10), 7.70-7.59 (5H, m, Ph, H-9, H-4), 7.36 (1H, dd, J =
9.4, 2.0 Hz, H-2), 7.26-7.22 (2H, m, Ph), 7.02 (1H, t, J = 6.1 Hz, 3-NHR), 5.81 (1H, d, J = 2.4 Hz, H-7), 5.76 (1H, t, J = 6.2 Hz, 8-NHR),
4.68 (2H, q, J = 7.1 Hz, NCH2CH3), 3.07 (2H, d, J = 6.1 Hz, 3-NHCH2
tBu), 2.78 (3H, s, CH3SO3
-), 2.57 (2H, d, J = 6.0 Hz, 8-NHCH2
tBu),
1.43 (3H, t, J = 7.1 Hz, NCH2CH3), 1.05 (9H, s, 3-NHCH2
tBu), 0.79 (9H, s, 8-NHCH2
tBu). dC (126 MHz, CDCl3): 156.32 (C), 152.38 (C),
148.23 (C), 134.48 (C), 132.18 (C), 130.77 (CH), 129.38 (CH), 129.30 (CH), 128.36 (C), 127.96 (CH), 124.40 (C), 123.66 (CH), 121.21
(CH), 117.82 (CH), 117.06 (C), 103.01 (CH), 97.95 (CH), 55.03 (CH2), 54.68 (CH2) , 49.07 (CH2), 39.58 (CH3) , 32.77 (C), 32.57 (C),
27.69 (CH3) , 27.55 (CH3), 14.33 (CH3). HRMS (ESI
+, m/z): found 454.3211. C31H40N3 ([M]
+) requires 454.3217.
3,8-Bis(neopentylamino)-5-(pentadeuteroethyl)-6-phenylphenanthridinium Mesylate (d5-Neo Mesylate)
Phenylphenanthridine 2 (100 mg, 0.24 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (1.0 mL) and stirred at 0
C under argon.
Pentadeuteroethyl triflate 6 (43 mg, 0.24 mmol, 1.0 eq.) was added followed by a further addition of CH2Cl2 (0.5 mL). The ice bathCell Chemical Biology 24, 1285–1298.e1–e12, October 19, 2017 e9
was removed and the solution was stirred for 20 h at RT under argon. H2O (3 mL) was added, the mixture was shaken and the layers
separated. The organic layer was dried over anhydrous MgSO4, filtered and concentrated under reduced pressure to give a purple
foam. The residue was loaded on a short silica plug, washed with Et2O (53 100 mL), eluted with CHCl3 and the solvent was concen-
trated under reduced pressure. The crude mixture was purified using preparative HPLC method by separate injections of 15 mg of
crude for each purification. Gradient elution of buffers A and Bwas from 60:40 to 45:55 over 45min. Pure fractions were collected and
combined. Brine was added, the solution was extracted with CHCl3, dried over anhydrous MgSO4, filtered and concentrated under
reduced pressure to give d5-Neo as a chloride salt. The solid was ion exchanged to themesylate form [IRA 401 resin inmesylate form,
loaded and eluted inMeOH-H2O (1:1)], furnishing d5-Neomesylate as a purple foam (57mg, 44%). tR = 20min. dH (500MHz, CDCl3):
8.12 (1H, d, J = 9.3 Hz, H-1), 7.85 (1H, d, J = 9.3 Hz, H-10), 7.81 (1H, apparent s, broad, H-4), 7.75-7.62 (3H, m, Ph), 7.58 (1H, dd, J =
9.2, 2.5 Hz, H-9), 7.37 (1H, dd, J = 9.3, 2.1 Hz, H-2), 7.32-7.27 (2H, m, Ph), 7.12 (1H, t, J = 6.1 Hz, 3-NHR), 5.88 (1H, d, J = 2.4 Hz, H-7),
5.39 (1H, t, J = 6.1 Hz, 8-NHR), 3.11 (2H, d, J = 6.0 Hz, 3-NHCH2
tBu), 2.81 (3H, s, CH3SO3
-), 2.62 (2H, d, J = 6.0 Hz, 8-NHCH2
tBu), 1.08
(9H, s, 3-NHCH2
tBu), 0.83 (9H, s, 8-NHCH2
tBu). dC (126 MHz, CDCl3): 156.50 (C), 152.65 (C), 147.92 (C), 134.66 (C), 132.27 (C),
131.84 (CH), 129.15 (CH), 129.00 (CH), 128.63 (C), 128.05 (CH), 124.34 (C), 123.72 (CH), 121.43 (CH), 117.38 (CH), 116.98 (C),
103.63 (CH), 97.82 (CH), 55.13 (CH2), 54.84 (CH2), 39.61 (CH3), 32.86 (C), 32.54 (C), 27.76 (CH3), 27.59 (CH3). HRMS (ESI
+, m/z): found
459.3514. C31H35D5N3 ([M]
+) requires 459.3531.
3,8-Bis(neopentylamino)-5-ethyl-6-phenylhydrophenanthridine (NeoH) and 3,8-Bis(neopentylamino)-6-deutero-5-
ethyl-6-phenylhydrophenanthridine (NeoD)
Neo mesylate (30 mg, 0.06 mmol, 1.0 eq.) was added to a tube flushed with argon and filled with degassed H2O (3.0 mL) and de-
gassed Et2O (3.0 mL). The mixture was shaken to dissolve under argon. Then NaBH4 (21 mg, 0.55 mmol, 10 eq.) was added to the
mixture, it was shaken for 5min under argon in the dark and the phases were left to separate for 1min. The organic layer was syringed
out to a vial flushed with argon; the aqueous layer was extracted again with degassed Et2O (3.0 mL) and the organic layer was sy-
ringed out to a vial. The organics were combined and the solvent was evaporated by argon flux furnishingNeoH as a pale green foam
(24mg, 99%). The crudewas characterized by 1HNMRand usedwithout purification in the next step. An identical result was obtained
when Neowas reducedwith NaBD4 to give NeoD. UV-visible and HPLC data are given in Figures S3 and S4. NeoH/D are air-sensitive
andNMRdatawere conveniently obtained for NeoD in a separate experiment in which 4.0mgNeowas dissolved in 0.6mL of CD2Cl2,
placed under argon in an NMR tube and a solution of 1.0 mg of NaBH4/D4 in 0.7 mL of D2O was added, the tube was shaken until the
purple colour disappeared and the NMR spectra were obtained. N.B. The same precautions apply as for MitoNeoH.
NeoH. dH (400MHz, CD2Cl2): 7.44 (1H, d, J = 8.5 Hz, H-10), 7.42-7.40 (1H, m, H-1), 7.21-7.13 (5H, m, C-6-Ph), 6.55 (1H, dd, J = 8.6,
2.3 Hz, H-9), 6.33 (1H, d, J = 2.3 Hz, H-7), 6.09 (1H, d, J = 8.3, H-2), 5.97 (1H, s, H-4), 3.42 (1H, dq, J = 14.3, 7.0 Hz, NCHACHB), 3.19
(1H, dq, J = 14.0, 7.0 Hz, NCHACHB), 2.90 (2H, s, NCH2), 2.84 (2H, s, NCH2), 1.18 (2H, t, J = 7.0 Hz, CH3), 1.00 (9H, s, NHCH2
tBu), 0.96
(9H, s, NHCH2
tBu).
Due to overlap of the C-H signal with the CD2Cl2 signal in the
1HNMR spectrum, the reduction of Neowith NaBH4/D4 (1.5mg scale)
was also obtained in CDCl3. Note: The reduction in CD2Cl2 is cleaner than that observed in CDCl3.
NeoH. dH (400MHz, CDCl3): 7.47-7.32 (2H,m, H-1, H-10), 7.17-7.06 (5H, m, Ph), 6.47 (1H, d, J = 8.6 Hz, H-9), 6.22 (1H, d, J = 2.5 Hz,
H-7), 6.04 (1H, d, J = 8.3 Hz, H-2), 5.90 (1H, s, H-4), 5.25 (1H, s, C-H), 3.40-3.27 (1H,m, NCHACHB), 3.17-3.07 (1H,m, NCHACHB), 2.84
(2H, s, NCH2), 2.75 (2H, s, NCH2), 1.16-1.04 (3H, m, CH2CH3), 0.93 (9H, s, NHCH2
tBu), 0.89 (9H, s, NHCH2
tBu).
NeoD. dH (400MHz, CD2Cl2): 7.44 (1H, d, J = 8.4 Hz, H-10), 7.41 (1H, d, J = 8.4 Hz, H-1), 7.22-7.12 (5H, m, C-6-Ph), 6.55 (1H, dd, J =
8.4, Hz, H-9), 6.33 (1H, s, H-7), 6.09 (1H, d, J = 8.3, H-2), 5.97 (1H, s, H-4), 3.47-3.37 (1H,m, NCHACHB), 3.23-3.13 (1H,m, NCHACHB),
2.90 (2H, s, NCH2), 2.85 (2H, s, NCH2), 1.21-1.13 (3H, m, CH3), 1.00 (9H, s, NHCH2
tBu), 0.96 (9H, s, NHCH2
tBu).
dH (400 MHz, CDCl3): 7.42-7.37 (2H, m, H-1, H-10), 7.17-7.05 (5H, m, C-6-Ph), 6.47 (1H, d, J = 8.4 Hz, H-9), 6.23 (1H, s, H-7), 6.04
(1H, d, J = 7.9 Hz, H-2), 5.90 (1H, s, H-4), 3.37-3.27 (1H, m, NCHACHB), 3.15-3.07 (1H, m, NCHACHB), 2.84 (2H, s, NCH2), 2.76 (2H, s,
NCH2), 1.14-1.08 (3H, m, CH2CH3), 0.93 (9H, s, NHCH2
tBu), 0.89 (9H, s, NHCH2
tBu).
3,8-Bis(neopentylamino)-5-(pentadeuteroethyl)-6-phenylhydrophenanthridine (d5-NeoH)
d5-Neomesylate (10mg, 0.02mmol, 1.0 eq.) was added to a tube flushedwith argon and filled with 1.0mL of degassed H2O, 1.0mL
of degassed Et2O and shaken to dissolve under argon. NaBH4 (7.0mg, 0.18mmol, 10 eq.) was added afterwards and themixture was
shaken for 5 min under argon in the dark and the phases were left to separate for 1 min. The organic layer was syringed out to a vial
flushed with argon; the aqueous layer was extracted again with 1.0 mL of degassed Et2O and the organic layer was syringed out to a
vial. The organics were combined and the solvent was evaporated by argon flux furnishing d5-NeoH as a pale green foam (8 mg,
99%). The crude was used without purification in the next step.
N.B. The same precautions apply as for MitoNeoH.
3,8-Bis(neopentylamino)-5-ethyl-2-hydroxy-6-phenylphenanthridinium Mesylate (NeoOH Mesylate)
Fremy’s salt (43 mg, 0.18 mmol, 4.0 eq.) was dissolved in 20 mL of phosphate buffer (pH 7.4), through which argon was bubbled
during 10min before addition of salt. Freshly preparedNeoH (20 mg, 0.04 mmol, 1.0 eq.), which was used immediately after the syn-
thesis, was dissolved in 0.5 mL of Et2O, transferred to the buffer and the mixture was stirred at RT under argon for 1 h in the dark. The
solution was extracted with CHCl3 (33 20mL), the organic layers combined, dried over anhydrousMgSO4, filtered and concentrated
under reduced pressure to give a raspberry red foam. The crude mixture was purified using preparative HPLC method by separate
injections of 10mg crude for each purification. Gradient elution of buffers A and Bwas from 58:42 to 50:50 over 45min. Pure fractions
were collected and combined. Brine was added, the solution was extracted with CHCl3, dried over anhydrous MgSO4, filtered ande10 Cell Chemical Biology 24, 1285–1298.e1–e12, October 19, 2017
concentrated under reduced pressure to give NeoOH as a chloride salt. The solid was ion exchanged to the mesylate form [IRA 401
resin in mesylate form, loaded and eluted in MeOH-H2O (1:1)], furnishingmesylate NeoOH as a raspberry red glass (10mg, 48%). dH
(500 MHz, CDCl3): 8.32 (1H, s, H-10), 7.96 (1H, apparent s, broad, H-1), 7.68-7.62 (3H, m, Ph), 7.40 (2H, m, Ph), 7.33 (1H, apparent s,
broad, H-9), 6.68 (1H, s, H-4), 6.08 (1H, apparent s, broad, 3-NHR), 5.91 (1H, d, J = 1.9 Hz, H-7), 4.57 (2H, q, J = 7.2 Hz, NCH2CH3),
4.44 (1H, apparent s, broad, 8-NHR), 3.11 (2H, d, J = 6.0 Hz, 3-NHCH2
tBu), 2.89 (3H, s, CH3SO3
), 2.65 (2H, d, J = 5.7 Hz,
8-NHCH2
tBu), 1.51 (3H, t, J = 7.1 Hz, NCH2CH3), 1.09 (9H, s, 3-NHCH2
tBu), 0.85 (9H, s, 8-NHCH2
tBu). HRMS (ESI+, m/z): found
470.3160. C31H40N3O ([M]
+) requires 470.3166.
3,8-Bis(neopentylamino)-2-hydroxy-5-(pentadeuteroethyl)-6-phenylphenanthridinium Mesylate (d5-NeoOH)
Fremy’s salt (22 mg, 0.09 mmol, 4.0 eq.) was dissolved in 10 mL of phosphate buffer (pH 7.4), through which argon was bubbled
during 10 min before addition of salt. Freshly prepared d5-NeoH (10 mg, 0.02 mmol, 1.0 eq.), which was used immediately after
its synthesis, was dissolved in 0.5 mL of Et2O, transferred to the buffer and the mixture was stirred at RT under argon for 1 h in
the dark. The solution was extracted with CHCl3 (3 3 10 mL), the organic layers combined, dried over MgSO4, filtered and concen-
trated under reduced pressure to give a raspberry red foam. The crudemixturewas purified using preparative HPLCmethod by sepa-
rate injections of 5 mg crude for each purification. Gradient elution of buffers A and B was from 58:42 to 50:50 over 45 min. Pure
fractions were collected and combined. Brine was added, the solution was extracted with CHCl3, dried over anhydrous MgSO4,
filtered and concentrated under reduced pressure to give d5-NeoOH as a chloride salt. The solid was ion exchanged to the mesylate
form [IRA 401 resin inmesylate form, loaded and eluted in MeOH-H2O (1:1)], furnishingmesylate d5-NeoOH as a raspberry red glass
(4.5 mg, 47%). tR = 12 min. dH (500 MHz, CDCl3): 8.27 (1H, d, J = 9.2 Hz, H-10), 7.99 (1H, apparent s, broad, H-1), 7.71-7.64 (3H, m,
Ph), 7.49-7.36 (2H, m, Ph), 7.34 (1H, d, J = 9.3 Hz, H-9), 6.62 (1H, s, H-4), 6.50 (1H, apparent s, broad, 3-NHR), 5.86 (1H, d, J = 2.2 Hz,
H-7), 4.34 (1H, apparent s, broad, 8-NHR), 3.11 (2H, d, J = 5.9 Hz, 3-NHCH2
tBu), 2.86 (3H, s, CH3SO3
-), 2.67 (2H, d, J = 5.8 Hz,
8-NHCH2
tBu), 0.95 (9H, s, 3-NHCH2
tBu), 0.89 (9H, s, 8-NHCH2
tBu). HRMS (ESI+, m/z): found 475.3457. C31H35D5N3O ([M]
+) requires
475.3480.
d15-MitoNeo Dimer
Potassium hexacyanoferrate (39 mg, 0.12 mmol, 10.0 eq.) was added to a solution of d15-MitoNeoD (obtained from the reduction of
MitoNeo (12 mg, 0.012 mmol) as described above) in MeCN (2 mL) and H2O (2 mL). The solution was stirred overnight then extracted
into CH2Cl2 (2 3 10 mL). The combined organic layers were washed with brine (3 3 50 mL), dried over anhydrous Na2SO4 and
concentrated under vacuum to give the dimer as a purple glass (8 mg, 67%,85% purity by HPLC-UV, RT 19.2 min). HPLC analysis
was conducted on a Shimadzu Prominence HPLC using a Phenomenex Kinetix 5m EVOC-18 (250mmx 4.6mm) column eluting 30%
MeCN in 0.1% TFA increasing to 80% MeCN over 30 min. HRMS (ESI+, m/z): found 392.7760. C106H92D30N6P2
4+ (M4+) requires
392.7766. Isotope pattern consistent with structure.
Structural Assignment of MitoNeoOH and NeoOH
MitoNeoOH and NeoOH have been assigned as the 2-hydroxy derivatives (Figure 1A). This was done by first assigning the 1H NMR
spectrum of Neo and then using this assignment to determine the position of substitution in NeoOH and by analogy MitoNeoOH. The
assignment of Neowas carried out by NMR experiments on the triflate salt, while those on NeoOH used the chloride salt and those on
MitoNeoOH on the mesylate salt. There are small differences in the chemical shifts and resolution of NMR signals for Neo salts de-
pending on the counterion (triflate, mesylate or chloride) and concentration, but the overall pattern and critical upfield shift of H-7 (see
below) is present in all. The triflate, mesylate and chloride salts could easily be interconverted by ion exchange and the salt with the
best resolved signals in theNMR spectra were used in each case. The fully assigned 1HNMRspectrum of Neo is shown in Figure S4E.
The basis of this assignment will be explained step-wise using the atom numbering shown in Figure S4F.
The chemical shifts, integrations and the matching coupling constants (7.1 Hz), allow the assignment of the 3H t at 1.54 ppm to the
three hydrogen atoms attached to C12 (i.e. H12) and the 2H q at 4.78 ppm (expansion in Figure S4G) to the two hydrogen atoms
attached to C11 (i.e. H11). This is also clear in the COSY spectra.
HSQC allowed the assignment of C11 to the signal at 49.5 ppm and C12 to the signal at 14.5 ppm by correlation to H11 and H12.
The two NH protons were also assigned since they show no correlation in the HSQC spectrum. Differentiating between the two NH’s
and the shown assignment to C8-NHR and C3-NHR (where R = neopentyl) was achieved below.
In the HMBC, the H11 q signal showed correlation to C12, plus correlation to quaternary carbons at 134.8 and 157.4 ppm. These
are therefore C4a and C6. At this stage the assignment of C6 to the signal at 157.4 ppm rather than 134.8 ppm is made on chemical
shift alone, and this assignment is confirmed below.
The H1-H2-H4 and H7-H9-H10 spins systems were identified by COSY. The final assignment of these was achieved using the 2H
dd J = 7.6, 1.6 Hz at 7.41 ppm, which was reliably assigned to H2’’ based on integration, multiplicity, coupling constants and the
COSY. With H2’’ assigned, the HMBC correlations H2’’-C6(157.4 ppm)-H7 and H11-C4a(134.8 ppm)-H1 confirmed the identities
of the spin systems. With H7 established, C7 was assigned to the signal at 105.1 ppm using HSQC, and HMBC correlation from
C7 used to assign the C8-NH.
Above, we have outlined the steps used to assign the distinctive upfield signal at 6 ppm to H7 in Neo, and hence the H7-H9-H10
spin system. This upfield signal is also found in the 1H NMR spectra of other N-alkyl 6-phenylphenanthridinium salts in the literature
and has consistently been assigned to H7. (Kreishman et al., 1971; Luedtke et al., 2005) It is also present in NeoOH at 5.97 ppm (chlo-
ride, 5.91 ppm mesylate). Thus, COSY confirms the H7-H9-H10 (5.97, 7.33 and 8.51 ppm) spin system is intact in NeoOH and the
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singlets in the 1H NMR spectrum of NeoOH, which have no COSY correlations, so can be assigned to the para-related protons H1
(8.66 ppm) and H4 (6.70 ppm). There is little change to the protons of the 6-phenyl ring (3H, 7.69-7.76 ppm and 2H, 7.41-7.47 ppm) as
would be expected from a distant change in structure, and there is no signal that could be assigned to a hydrogen atom attached
to C2.
The signals for the phenanthridinium ring system in the spectra of MitoNeoOH and NeoOH with the same counterion are very
similar. Detailed analysis of MitoNeoOH was carried out using the NMR spectra of the mesylate because this was the well resolved.
The distinctive upfield shift of H7 allows the COSY (Figure S4H, atom numbering in Figure S4I) to confirm that the H7-H9-H10 spin
system is intact and the assignment of two singlets shown in red to H1 and H4, demonstrating that the addition regiochemistry is the
same for both NeoOH and MitoNeoOH.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed using GraphPad Prism. Statistical values including the exact n, the test used and the statistical
significance are also reported in the Figure Legends.e12 Cell Chemical Biology 24, 1285–1298.e1–e12, October 19, 2017
